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ABSTRACT

A system and methods for controlled gene delivery comprising condensed nucleic acids complexed with polylinkers, wherein the complexes are covalently andor noncovalently bound to the surface of a substrate capable of
supporting cell adhesion. The gene delivery system achieves
temporal and spatial control of nucleic acid delivery to a
target cell or cells through control of complex density on the
surface of the support substrate, and reversibility of the
attachment of the polylinker to the support substrate. The
system and method of the invention can be used to create
spatial patterns of gene expression, and in tissue engineering, high throughput screening, and gene therapy applications.
26 Claims, 30 Drawing Sheets
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CONTROLLED SURFACE-ASSOCIATED
DELIVERY OF GENES AND
OLIGONUCLEOTIDES
CROSS-REFERENCE TO RELATED
APPLICATIONS
The present application is a continuation-in-part of U.S.
application Ser, No, 101076,060, filed Feb, 14, 2002, now
U.S. Pat. No. 6,890,556, which claims priority to provisional
application Ser. No. 601268,626, filed Feb. 14, 2001, the
disclosures of which are hereby incorporated by reference in
their entireties, Applicants claim the benefits of this application under 35 U.S.C. §I19 (e) and §35 U.S.C. 120.
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GOVERNMENT RIGHTS CLAUSE

neresearch leading to the present invention was supported by National Science Foundation Grant Number R01GM066839-0141 and National Institutes of Health Grant
Number BES-0092701, Accordingly, the Government has
certain rights in the invention.
FIELD OF THE INVENTION
The present invention relates to methods for the controlled delivery of a nucleic acid into a cell. More specifically, the invention relates to methods of targeting
- and
controlling the delivery of a nucleic acid to a cell or cell
population with a system comprising DNA complexed to a
polylinker which is attached to a support substrate.
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BACKGROUND OF THE INVENTION
35

Developing systems capable of controlled and efficient
gene transfer is a fundamental goal of biotechnology, with
applications ranging from basic science to clinical medicine.
Increasing or decreasing the expression level of a gene
within a cell has the power to reveal or confirm the roles of
specific components of signaling pathways and can lead to
a mechanistic understanding of cell behavior, disease pathogenesis, and drug action. The successful application of gene
transfer for basic science and clinical medicine requires the
ability to manipulate the expression of target genes in the
desired cell population. A variety of approaches are being
taken to develop techniques to overcome barriers to gene
transfer, which includes processes such as cellular internalization, endosomal escape, and nuclear trafficking.
Cationic polymers provide a versatile approach for gene
transfer as the polymers can be designed or modified to
overcome some of the current problems encountered with
gene transfer. Complexation with cationic polymers functions to condense DNA, to produce a complex with a
less-negative surface charge, to enhance cellular internalization of DNA, and to protect the DNA from degradation.
Although many types of cationic polymers have been
explored (see, for example, van de Wetering et al. (1999)
Bioconjug. Chem. 10:589-597), polymers based on poly(Llysine) (PLL)(see, for example, Choi et al. (1999) Bioconjug. Chem. 10:62-65), poly(ethy1enimine) (PEI) (see, for
example, Blessing et al. (2001) Bioconjug. Chem.
12:529-537), poly(amidoamine) (PAMAM) (see, for
example, Qin et al. (1998) Hum. Gene Ther. 9:553-560),
poly(2-dimethylamino)ethylmethacrylate
and
(p(DMAEMA)) (Arigita et al. (1999) Pharm. Res.
16:1534-1 541) are among those utilized.
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PEI covalently attached to a biodegradable polymer surface and to surface-immobilized collagen has been used as
a gene delivery system. For example, Zheng et al. (2000)
Biotechnol. Prog. 16:254-257, created a polymer surface
with attached PLL and PEI, to which DNA was nonspecifically adsorbed for delivery into a cell.
Recently, polymeric systems originally developed to
deliver biologically active proteins have been adapted to
deliver non-viral DNA. Polymeric scaffolds have been fabricated from a variety of materials, both natural (e.g.,
collagen) and synthetic (e.g., pol~(lactide-co-gl~colide))
which function as a support for cell adhesion and migration.
These scaffolds act to increase the local concentration of
DNA within the cellular microenvironment either by providing a sustained release of DNA (Shea et al. (1999) Nat.
Biotechnol. 17:551-554) or by maintaining the DNAlocally
(Bonadio et al. (1999) Nat. Med. 5:753-759). Bielinska et al.
(2000) Biomaterials 21:877-887 describe the use of a solid
membrane as a device for DNA
mediated
dendrimers
skin
systems
have also been developed that increase cell-surface concentrations of DNAby adsorbing DNAcomplexes to the surface
(Luo et al. (2000) Nat. Biotechnol. 18:893-895). U.S. Pat.
NO. 6,312,727 describes a nucleic acid delivery vehicle in
which comnlexes formed from nucleic acids condensed with
cationic polymer material are reacted with hydrophilic polymer material to form a hydrophilic coating or shield around
the complex,
SUMMARY OF THE INVENTION
The present invention provides for novel systems for the
controlled delivery of a nucleic acid to a target cell or cells
that combines nucleic acid condensation with polymeric
delivery by tethering or immobilizing nucleic acid complexes to a surface that supports cell adhesion. The gene
delivery system of the invention allows both temporal and
spatial control of gene delivery due to efficient internalization of the immobilized complex, elevated DNA concentrations in the microenvironment of cells adhered to the support
substrate, and through alterations in the number of tether to
the complexes and reversibility of complex immobilization.
The present invention also provides gene delivev by
plasmids that are complexed with cationic polymers (polyplexes) or lipid (lipoplexes) and subsequently immobilized
to cell culture or biomaterial substrates by adsorption. Polyplexes and lipoplexes were adsorbed to either unmodified
(PS) or serum-adsorbed (FBS-PS) polystyrene, The quantity
of DNA immobilized increases with time of exposure, and
the deposition rate and final amount deposited depends upon
the properties of the substrate and complex. For maximal
transfection, this approach requires that the affinity of the
DNA complex for the substrate must be sufficient to support
immobilization, yet not excessive to limit cellular internalization.
The studies reported on herein have focused on manipulating the properties of the complex and substrate to modulate this binding affinity. Polyplexes and lipoplexes were
examined based on their differences in chemical composition, size, and zeta potential, which may affect their interaction with the substrate. Additionally, serum adsorption
was used as a simple approach to modulate the interaction of
these complexes with the culture substrate. Substrate binding andcellulartransfection (i.e., transfectedcells, transgene
expression) were measured for polyplexes and lipoplexes
formed with varying amounts of cationic polymer or lipid,
respectively. The mechanism of gene transfer was examined
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through the distribution and stability of complexes on the
bonded to the support substrate. In a specific embodiment, a
substrate. Furthermore, the invention demonstrates that subcovalent bond between a polylinker and the support substrate-mediated delivery can transfect primary human-destrate is broken after a cell is plated on the support surface.
rived cells, and that this approach can be extended to widely
In specific embodiments, the nucleic acid is DNA, RNA,
5 or an oligonucleotide. In a more specific embodiment, the
used biomaterials.
For polyplexes, serum modification maximally enhanced
oligonucleotide is an antisense oligonucleotide or catalytic
reporter gene expression 1500-fold relative to unmodified
RNA capable of interfering with the expression of a gene. In
another more specific embodiment, the DNAor RNAdirects
substrates, and yields equivalent or greater expression compared to bolus delivery. For lipoplexes, serum modification
the intracellular expression of a gene.
In more specific embodiments, the polylinker is a cationic
significantly increased the number of transfected cells rela- l o
tive to unmodified substrates, yet provided similar levels of
polymer, cationic lipid, cationic protein, or cationic peptide.
expression. Immobilized complexes transfect primary cells
In a specific embodiment, the polylinker is a cationic polywith lower cytotoxicity relative to bolus delivery. This
mer or cationic peptide.
substrate-mediated delivery approach was successfully
The support substrate of the invention is any substrate
applied to a widely used biomaterial, poly(1actide-co-gly- 1s capable of supporting cell adhesion. In more specific
colide).
embodiments, the support substrate is glass, collagen, pepThe invention also provides a substrate mediated strategy
tide polymers, polysaccharide polymers, carbohydrate,
for delivering DNA complexes from hyaluronic acid (HA)polymers, polystyrene, lipid, metal, plastic, alumina gels,
collagen hydrogels. Hydrogels were formed by crosslinking
nitrocellulose, nylon membranes, cotton, or glass wool. In
HAwith poly(ethy1ene glycol) diglycidyl ether, and a topog- 20 another embodiment, the support substrate is HA-collagen
hydrogel. The support substrate either contains or can be
raphy was introduced using pattern transfer. DNMPEI complexes of varied sizes were immobilized to the hydrogel
chemically modified to contain a functional group that
allows the support substrate to covalently bind to a bifuncsubstrate using biotidneutravidin binding and non-specific
adsorption.
tional crosslinker or polylinker modified to have a functional
Accordingly, in a first aspect, the invention features a 25 group.
controlled nucleic acid delivery system comprising nucleic
In the controlled nucleic acid delivery system of the
acid-polylinker complexes tethered or immobilized to a
invention, nucleic acid delivery is controlled through (i)
complex density at the surface of the support substrate, (ii)
support substrate, wherein the nucleic acid-polylinker complex is capable of being delivered or internalized by a cell
complex location on the surface of the support substrate, and
30 (iii) the number of bonds linking the polylinkers in the
adhering to the support substrate.
The nucleic acid-polylinker complexes are immobilized
complex to the support substrate. In one embodiment, the
to the surface of a support substrate by a functional group
bonds between the polylinkers and the support substrate are
attached to the polylinker. A polylinker modified by a
reversible. In a specific embodiment, complex density on the
functional group may attach to the support substrate directly
surface of the support substrate ranges from 0.01 to 10.0 pg
or may attach through a modifying functional group present 35 DNA/cm2; and in a more specific embodiment, from 0.05 to
on the support substrate. The polylinker may be modified
5.0 pg D N A / c ~ ' .
with a functional group before or after formation of the
The relative strength of the attachment between the
complex, but the complex must be formed prior to attachimmobilized complex and the support substrate, and the
ment to the solid support. The polylinker may be modified
reversibility of complex immobilization at the surface of the
with a functional group before or after formation of the 40 support substrate are factors that determine the release rate
complex, but the complex must be formed prior to attachof a complex from the support substrate, and the availability
ment to the solid support.
of the released complex for internalization, e.g., delivery, to
The complexes may be covalently or non-covalently
a cell or cell population.
immobilized. In one embodiment, the complexes are
In a second aspect, the invention features a method of
covalently attached to the support substrate. In this embodi- 45 controlled nucleic acid delivery, comprising (a) contacting a
ment, the complexes may be formed by condensation of the
nucleic acid with a polylinker, wherein the nucleic acid
nucleic acid with a non-modified polylinker. The complex is
complexes with the polylinker to form a nucleic acidthen reacted with a functional group on the support substrate
polylinker complex, and (b) immobilizing the nucleic acidto generate a covalent bond between the polylinker and the
polylinker complex of step (a) to a support substrate able to
support substrate. In another embodiment of the covalent 50 support cell adhesion, wherein the immobilization is through
attachment of the complexes to the support substrate, the
the polylinker, and wherein delivery of the nucleic acid to a
nucleic acid is condensed with a modified polylinker. The
cell is controlled by (i) density and location of the complex
resulting complex is then reacted with a functional group on
on the surface of the support substrate, and (ii) the number
the solid support to generate a covalent bond between the
of bonds attaching the polylinkers in the complex to the
polylinker and the support substrate. In another embodi- 55 support substrate.
ment, the complexes are non-covalently immobilized to the
In specific embodiments, the complexes may be
support substrate. In this embodiment, the complexes may
covalently or non-covalently immobilized through the
be formed by condensation of the nucleic acid with a
polylinker to the support substrate. In one embodiment, the
non-modified polylinker. The complex is then modified with
complexes are covalently attached to the support substrate.
a functional group that will specifically interact with a 60 In another embodiment, the complexes are non-covalently
functional group on the solid support to generate a nonimmobilized to the support substrate. In either embodiment,
covalent bond. In another embodiment of the non-covalent
the complexes may be formed by condensation of the
attachment of the complexes to the support substrate, the
nucleic acid with a modified polylinker, by condensation of
nucleic acid is condensed with a modified polylinker. The
the nucleic acid with a non-modified polylinker, or by
complex is then reacted with a functional group on the solid 65 condensation of the nucleic acid with a mixture of modified
support to generate a non-covalent bond. In one embodipolylinker and non-modified polylinker. The number of
ment, more than 0.2% of the immobilized complexes are
bonds linking the polylinker to the support substrate can be
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manipulated by i) varying the extent of modification of the
face of a support substrate, wherein the surface of the
polylinker, or ii) varying the ratio of modified to nonsupport substrate is modified with a second functional group
modified polylinker during complex formation.
capable of interacting with the first functional group, and
In one embodiment, the support substrate is modified with
wherein the modified polylinker present in the complex is
a functional group capable of interacting with the non- 5 specifically bound to the support surface, and wherein the
modified polylinker in the complex. In another embodiment,
specifically bound complexes are released at desired times
the polylinkers are modified with a first functional group
and internalized by a cell adhering to the surface of the
prior to step (a) and the support substrate is modified with a
support substrate.
second functional group capable of interacting with the first
In a sixth aspect, the invention features a method of
functional group. In one embodiment, the nucleic acid is l o temporally and spatially controlling the delivery of a nucleic
contacted with both modified and unmodified polylinkers,
acid to a cell population comprising: (a) modifying a
forming nucleic acid-polylinker complexes which bind to
polylinker with a first functional group; (b) contacting a
the support substrate with varying binding strengths, and
nucleic acid with modified polylinker; wherein the nucleic
thus are released over a period of time as a result of the
acid complexes with the polylinker to form a condensed
different bond strengths. In another embodiment, the bond 1s nucleic acid; and (c) immobilizing the nucleic acidbetween the polylinker and the support substrate is reverspolylinker complex to a surface of a support substrate,
ible. In a further embodiment, the support substrate may be
wherein the surface of the support substrate is modified with
modified with a second functional group able to interact with
a second functional group capable of interacting with the
the first functional group modifying a polylinker. In a
first functional group, and wherein complexes formed with
specific embodiment, polylinker is poly-L-lysine (PLL), the 20 modified polylinker are specifically bound to the support
first functional group is biotin, and the second functional
surface and located at specific regions of the substrate in a
defined pattern, and wherein the specifically bound comgroup is avidin, strepavidin, or an avidin derivative.
In a third aspect, the invention features a method of
plexes are released at desired times and internalized by a cell
making a controlled nucleic acid delivery system, comprisadhering to the surface of the support substrate.
In a seventh aspect, the invention provides methods for
ing (a) contacting a nucleic acid with polylinkers; wherein 25
the nucleic acid complexes with the polylinkers to form a
increasing transgene expression. In one embodiment, the
condensed nucleic acid; and (b) immobilizing the polylinker
method comprises making a controlled nucleic acid delivery
present in the complex to a support substrate, wherein
system, comprising forming nucleic acid polylinker comdelivery of the nucleic acid to a cell is controlled by (i)
plexes, wherein the complexes are covalently or non-codensity and location of the complex on the surface of the 30 valently immobilized to the surface of a support substrate,
support substrate, and (ii) reversibility of the attachment of
and wherein the method comprises:
the polylinker to the support substrate the number of bonds
a) contacting a nucleic acid with a polylinker to form a
linking the polylinker in the complex to the support substrate
nucleic acid-polylinker complex;
wherein a desired release rate is achieved. In one embodib) immobilizing the nucleic acid-polylinker complex to a
support substrate; and wherein the cells are added to the
ment, the polylinkers are modified with a first functional 35
group prior to step (a) and the support substrate is modified
support substrate after immobilization of the nucleic
with a second functional group capable of interacting with
acid-polylinker complex to the support substrate.
the first functional group. In a further embodiment, the
In another embodiment, the method further comprises
nucleic acid is contacted with both modified and unmodified
modification of the support substrate with serum prior to
40 addition of the nucleic acid-polylinker complex, and
polylinkers.
In a fourth aspect, the invention features a method of
wherein said modification allows for an increase in transspatially controlling the delivery of a nucleic acid to a cell
gene expression.
In yet another embodiment, the extent of transgene
comprising: (a) modifying a polylinker with a first functional group; (b) contacting a nucleic acid with modified
expression is dependent upon substrate modification and
polylinker; wherein the nucleic acid complexes with the 45 complex formation. In a particular embodiment, the nucleic
polylinker to form a condensed nucleic acid; and (c) immoacid polylinker complexes are polyplexes or lipoplexes. In a
bilizing the nucleic acid-polylinker complex to a surface of
particular embodiment, the increase in transgene expression
a support substrate, wherein the surface of the support
occurs when the polyplexes are immobilized to the support
substrate is modified with a second functional group capable
substrate at low densities or low doses, such as, but not
of interacting with the first functional group, and wherein 50 limited to the doses used herein. The optimal doses and
complexes formed with modified polylinker are specifically
densities of the polyplexes andlor lipoplexes may depend on
bound to the support surface, and wherein the specific
the support substrate used, as well as the cell type for which
binding of the complexes to the surface of the support
gene delivery is desired. The methods for determining such
substrate is located at specific regions of the substrate in a
would be known to one skilled in the art. In yet another
55 particular embodiment, the increase in transgene expression
defined pattern.
In one embodiment, the nucleic acid is contacted with
is optimized at a particular NIP ratio, which also may be
both modified and unmodified polylinker in step (a) and the
optimized depending on the substrate used and the cell type
unmodified polylinker in the complex is not bound to the
for which gene delivery is desired.
support surface in step (c). In a specific embodiment, the
In yet another particular embodiment, the support subsubstrate is a microtiter plate comprising multiple wells.
60 strate is biodegradable or non-biodegradable. In a more
In a fifth aspect, the invention features a method of
particular embodiment, the support substrate is polystyrene
temporally controlling the delivery of a nucleic acid to a cell
(PS), gold, or poly(1actide-co-glycolide) (PLG). In yet
population comprising: (a) modifying a polylinker with a
another particular embodiment, the support substrate is a
first functional group; (b) contacting a nucleic acid with
hydrogel. In a more particular embodiment, the hydrogel is
modified polylinker; wherein the nucleic acid complexes 65 hyaluronic acid (HA)-collagen hydrogel.
with the polylinker to form a condensed nucleic acid; and (c)
In yet another embodiment, the support substrate may be
immobilizing the nucleic acid-polylinker complex to a surtreated with (modified) serum, such as but not limited to,

fetal bovine serum. In a particular embodiment, the delivery
In another particular embodiment, the nucleic acid is
of the nucleic acid-polylinker complexes to cells occurs
DNA, RNA or an oligonucleotide. In a more particular
from a polystyrene surface treated with serum, and such
embodiment, the oligonucleotide is an antisense oligonucledelivery results in a similar or a greater percentage of
otide or a catalytic RNA capable of interfering with the
transfected cells relative to bolus delivery. In yet another 5 expression of a gene.
particular embodiment, such delivery further comprises
In yet another particular embodiment, the polylinker is a
release of the nucleic acid from the nucleic acid-polylinker
cationic polymer, cationic lipid, cationic protein, or cationic
complexes, and the release is maximized when the support
peptide.
. .
substrate is pretreated with serum. In yet another
Other objects and advantages will become apparent from
embodiment, the release of nucleic acid from the nucleic 10 a review of the ensuing detailed description taken in conacid-polylinker complexes is further enhanced when the
junction with the following illustrative drawings.
support substrate containing the complexes is incubated in
BRIEF DESCRIPTION OF THE FIGURES
conditioned medium. In yet another particular embodiment,
the delivery of the nucleic acid-polylinker complexes to
FIG. 1 is a schematic depiction of DNA condensation
cells from a serum-modified support substrate results in 15
(ionically localized) with polymeric delivery to tether DNA
higher cellular association of the nucleic acid-polylinker
complexes to the surface of a hydrogel.
complexes with the support substrate.
FIG. 2 is a schematic depiction of the coupling of DNA
In an eighth aspect, the invention provides a method for
complexes to the surface with a bifunctional cross-linker.
increasing transgene expression, comprising the steps of
FIG. 3 shows the quantity of surface associated DNA
a) making a controlled nucleic acid delivery system by 20
obtained following trypsinization of the slide.
contacting a nucleic acid with a polylinker to form a
FIG. 4 shows the surface density of tethered DNMPolynucleic acid-polylinker complex;
Lysine-Cys complexes.
b) immobilizing the nucleic acid-polylinker complex to a
FIG. 5 depicts a method of surface modification and DNA
support substrate; wherein said immobilizing is accom25 tethering.
plished by covalent or non-covalent means, and
c) adding the cells into which transgene expression is
FIG. 6 shows the chemical structures of bifunctional
cross-linkers exemplifying some of the types of compound
desired to the support substrate after immobilization of
that can be employed by the present invention. These
the nucleic acid-polylinker complex to the support
cross-linkers are bifunctional, e.g., having two reactive
substrate.
In one particular embodiment, the support substrate com- 30 centers. As shown, these molecules have their reactive
centers at opposite ends and can be used to bind two
prises a biodegradable or non-biodegradable material. In a
molecules together.
more particular embodiment, the biodegradable material is
poly(1actide-co-glycolide) or a hydrogel and the non-biodeFIG. 7 shows the results of HPLC analysis of the formation of biotinylated K,,, starting material l and the reaction
gradable material is polystyrene. In a more particular
embodiment, the hydrogel is hyaluronic acid (HA)-collagen 35 mixture 2. The shift in molecular weight between 1 and 2
and absence of the low molecular weight peak in 2 conhydrogel.
firmed that the reaction went to completion.
In yet another particular embodiment, the nucleic acidFIG. 8 shows the results of mass spectrometric analysis of
polylinker complexes are formed prior to attachment to the
the purified reaction mixture of the formation of biotinylated
solid support substrate.
In yet another particular embodiment, the method pro- 40 K19.
FIG. 9 shows the density of surface-associated DNA for
motes transfection of primary cells. In a particular embodicomplexes formed by mixing K,,,-B DNA with either K,,
ment, the primary cells are fibroblast cells, although any
or K,,, at a charge ratio of 5.5. The moles of biotin per mole
primary cell or cell line for which gene delivery is desired
DNA (i.e., average number of biotin groups per complex),
may be envisioned by the present invention. These may
include neuronal cells, skin cells, stem cells, tumor cells and 45 which varied from 28 to 1705 for K,,,-B and 217 to 4342
the like.
for K,,-B, are listed beneath each bar. The symbol *
indicates statistical significance (pe0.05) in the surface
In yet another particular embodiment, the nucleic acid
densities relative to complexes without biotin.
polylinker complexes are immobilized to the support subFIG. 10 shows the density of surface-associated DNA for
strate using biotin and avidin or an avidin derivative, such as
streptavidin or neutravidin. In yet another particular embodi- so complexes formed by mixing K,,-B DNA with K,,,-B with
ment, the nucleic acid-polylinker complexes are immobieither K,, or K,,, at a charge ratio of 5.5 as described in
lized to the support substrate by non-specific adsorption.
FIG. 11.
FIG. 11 shows the expression levels achieved by surface
In yet another particular embodiment, the method further
mediated transfection after 48 hours of incubation for
comprises controlling the size of the nucleic acid polylinker
complex by regulating the salt content during complex 55 HEK293T cells determined using an assay for fl-galactosiformation. In a more particular embodiment, the forming of
dase activity. The symbol * indicates statistical significance
large diameter complexes in the presence of salt results in
in transfection levels (pe0.05) relative to both bulk delivery
increased transgene expression, and the forming of small
conditions.
diameter complexes in the absence of salt results in a greater
FIG. 12 shows the expression levels achieved by surface
percentage of cells being transfected. In a more particular 60 mediated transfection after 48 hours of incubation for NIHI
3T3 cells as described in FIG. 11.
embodiment, the salt is sodium chloride.
In yet another particular embodiment, the method further
FIG. 13 shows expression levels achieved by surface
comprises release of the nucleic acid from the substrate,
mediated transfection after 96 hours of incubation for
wherein the release is optimized by using conditioned
HEK293T cells.
medium. In a more particular embodiment, the method 65
FIG. 14 shows expression levels achieved by surface
further comprises biotinylation of the complex to enhance
mediated transfection after 96 hours of incubation for NIHI
release of the complex from the substrate.
3T3.
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FIG. 15 shows the diameter and zeta-potential of DNA
complexes. (A) z-average diameter and (B) zeta potential of
PEI polyplexes with increasing polymerlDNA ratio (NIP).
(C) z-average diameter and (D) zeta potential of Lipofectamine 2000 lipoplexes with increasing volumes of lipid 5
used to complex 1 pg of DNA. Data is presented as average
+ standard deviation of the mean. * indicates pe0.05 relative
to remaining data (A). ** indicates pe0.05 relative to NIP
05
to 0.5 pL of
equal to 5 (B). *** indicates ~ ~ 0 . relative
lipid. For this and all other figures, p values were obtained l o
using the Student's t test with single comparisons.
FIG. 16 Shows the X-ray photoelectron spectrum of
polystyrene and a serum modified polystyrene surfaces. The
peak denoted by the arrow indicates the presence of nitrogen
l5
on the substrate.
FIG. 17 shows DNA deposition and stability. (A) Polyplexes (circles) and lipoplexes (triangles) were deposited
onto polystyrene ( 0 ,A) and serum coated polystyrene (0,
A) for 24 hours. Substrates were incubated with 2 pg of
DNA. (B) Immobilized polyplexes and lipoplexes were 20
exposed to phosphate buffered saline (PBS, pH=7.4) at 37'
C. Data is presented as average +standard deviation of the
mean. * indicates pe0.05 relative to FBS-PS deposition of
polyplexes after 24 hours. ** indicates ~ ~ 0 . relative
05
to
lipoplexes released from PS at 8 days.
25
FIG. 18 shows DNA adsorption to surface. Polyplexes
and lipoplexes were incubated on (A) PS and (B) FBS-PS
surfaces for 2 hours. Black bars indicated 2 pg and gray bars
indicated 0.5 pg of DNA incubated on the surface. Data is
presented as average +standard deviation of the mean. High 30
doses have pe0.05 relative to corresponding low doses at the
same NIP (A). * indicates pe0.05 relative other polyplex
conditions.
FIG. 19 shows transgene expression by substrate-medi- 35
ated delivery. (A, B) Polyplexes and (C, D) lipoplexes with
plasmid encoding for luciferase were incubated on substrates at low (0.5 pg; A, C) and high (2.0 pg; B, D) doses
for 2 hours. Bolus delivery used equivalent amounts of DNA
that were immobilized to the substrate: (A) 0.2 pglcm2, (B) 40
0.5 pglcm2, (C) 0.25 pglcm2 and (D) 0.1 pglcm2. Activity
was normalized to the number of cells seeded. Data is
presented as average +standard deviation of the mean. *
indicates pe0.05 relative to other delivery methods for that
condition. ** indicates pe0.05 at different complex condi- 45
tions.
FIG. 20 shows transfected cell numbers by substratemediated delivery. Lipoplexes with plasmid encoding for
GFP were incubated on substrates with quantities of (A) 0.5
pg and (B) 2 pg for 2 hours. Bolus delivery used equivalent 50
amounts of DNA that were immobilized to the substrate: (A)
0.25 pgIcm2 and (B) 0.1 pgIcm2. Data is presented as
average +standard deviation of the mean. * indicates pe0.05
relative to the other delivery methods for that condition.
FIG. 21 shows release of adsorbed complexes upon 55
exposure to conditioned media. Polyplexes (circles) and
lipoplexes (triangles) (2 pg) were adsorbed to (A) PS and (B)
FBS-PS substrates and exposed to conditioned media at 37'
C. Data is presented as average +standard deviation of the
mean. Data points at 0.5 days and above are at pe0.05 60
relative to delivery with the other vector at each time point
for each surface.
FIG. 22 shows distribution of cells and polyplexes on
substrate following cell culture. Confocal microscopic
images of polyplexes on (A) PS and (B) FBS-PS 20 hours 65
after cell seeding. Polyplexes (2 pg, NlP=25) was incubated
on substrates for 2 hours. Images captured 20 hours after cell

10
seeding. Plasmid was labeled with tetramethyl-rhodamine
and cells were stained with fluorescein diacetate.
FIG. 23 shows transfection of primary human dermal
fibroblasts. (A) GFP expression from bolus delivery of 0.5
pg lipoplexes. (B) GFP expression from FBS-PS substratemediated delivery of 1 pg lipoplexes incubated on substrate.
Luciferase activity from substrate and bolus delivery of (C)
polyplexes and (D) lipoplexes. Data is presented as average
+standard deviation of the mean. * indicates pe0.05 relative
to other delivery methods for that condition.
FIG. 24 shows substrate-mediated transfection from
serum coated PLG. Polyplexes (5 pg) containing plasmid
encoding for 0-galactosidase were incubated for 24 hours.
Transfected cells appear blue, as indicated with the arrow.
FIG. 25 shows (A) z-average diameter of DNMPEI
complexes at NIP ratios of 2.5, 5, 10 and 20 for complexes
formed in 150 mm NaCl or water. (B) Zeta potential of
DNMPEI complexes at NIP ratios of 2.5, 5, 10 and 20 for
complexes formed in 150 mm NaCl. Plotted data is an
average of triplicate conditions.
FIG. 26 shows DNMPEI complex aggregation. Complexes were formed in water at different NIP ratios and
complex size was monitored following addition of salt to the
complexes, Plotted data is an average of triplicate conditions.
FIG. 27 shows surface densities of DNMPEI complexes
immobilized to HA collagen-NA hydrogels for complexes
formed in 150 mm NaCl or water (A). Plotted data is an
average of triplicate conditions. Fluorescence photomicrographs of immobilized biotinylated DNMPEI complexes
(NIP=5) to HA-collagen-NA hydrogels. Biotinylated complexes formed in water (B) or 150 mm NaCl (C) were
incubated on the substrate for 120 min. Images were captured after washing the substrate with PBS buffer.
FIG. 28 shows spatially controlled gene transfer of NIHI
3T3 cells plated on topographically patterned HA-collagenNA hydrogels with immobilized DNMPEI complexes.
Overlay of GFP positive cells and rhodamine phalloidin
staining are shown. Magnifications correspond to 100x(A)
and 200x(B).
FIG. 29 shows transgene expression in NIH/3T3 cells
mediated by immobilized complexes to HA-collagen-NA
substrates. % biotinylated pEI indicate the percent biotinylation of the complexes, The symbols * and ** represents a
statistically significant level of pe0.05 and e0.01; respectively, for single comparisons between biotinylated complexes and non-biotinylated complexes. Complexes were
formed at an NIP ratio of 5. Plotted data is an average of
triplicate conditions.
FIG. 30 shows GFP transgene expression in NIH/3T3
cells mediated by immobilized complexes to HA-collagenNA substrates. The cell nuclei are stained with HOESCHT
dye for visualization (A). The percentage of transfected cells
was calculated by dividing the number of GFP positive cells
by the total number of nuclei. The symbol *** represents a
statistically significant level of pe0.0001 for a single comparison between large and small complexes. Complexes
were formed at an NIP ratio of 5. Plotted data is an average
of triplicate conditions.
FIG. 31 shows release kinetics of biotinylated and nonbiotinylated complexes immobilized to HA-collagen-NA
hydrogels against PBS (A), conditioned media (B) or hyaluronidase (C). Complexes containing 0% and 25% biotinylated PEI were immobilized to the hydrogel substrates. The
symbols * and *** represents a statistically significant level
of pe0.05 and ~0.001;respectively, for single comparisons

US 7,029,697 B2
11
between biotinylated complexes and non-biotinylated complexes. Plotted data is an average of triplicate conditions.
FIG. 32 shows luciferase transgene expression in NIHI
3T3 cells mediated by immobilized complexes to HAcollagen-NA substrates for cells durectly attached to the
hydrogel (open diamonds) or not in contact with the hydrogel (closed diamonds). % biotinylated PEI indicate the
percent biotinylation of the complexes. All complexes were
formed at an NIP ratio of 5. Plotted data are an average of
triplicate conditions.
FIG. 33 shows luciferase transgene expression in NIHI
3T3 cells mediated by immobilized complexes to HAcollagen-NA substrates. % RGD-PEI indicates the percent
RGD modification of the complexes. DNMPEI complexes
were formed (NIPF5) with mixtures of three types of PEI:
biotinylated, RGD-modified and unmodified. The percentage of biotinylated PEI was kept constant at 25% and the
percentage of RGD-PEI was varied from 0% to 75% to
obtain different quantities of RGD in the complex. Plotted
data is an average of triplicate conditions.
FIG. 34 shows photomicrographs of GFP expressing cells
in patterns on gold surfaces. a) Overlay of GFp photomicrograph on phase photomicrograph. b) Photomicrograph of
just GFP-expressing cells.
FIG. 35 shows luciferase transgene expression in NIHI
3T3 cells mediated by immobilized complexes to
alkanethiol modified gold surfaces. DNA was complexed
with Lipofectamine, deposited onto gold for 2 hours, surfaces were washed and cells were then seeded. Luciferase
expression was assayed for 24 hours later.
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of being internalized by a cell in the nucleic acid-polylinker
complex of the invention. The internalized nucleic acid may
encode a protein, a growth factor, a hormone, etc., or may be
an antisense oligonucleotide which interferes with the
5 expression of a gene. The instant invention provides a
condensed nucleic acid in the form of a nucleic acidpolylinker complex immobilized on the surface of a support
substrate; the complex is released from the surface of the
support subtrate into the cell microenvironment, and is
10 capable of being internalized by the cell. As shown in the
experiments reported below, a cell taking up the released
complex is transformed and able to express the transgene of
the internalized complex.
The terms "support substrate", "solid substrate", "solid
15 support", "support" and "supporting scaffold" are used interchangeably and represent a material that binds a polylinker
which is complexed with a nucleic acid, which provides a
surface for a cell to interact with the nucleic acid associated
with the solid substrate, and which is biocompatible, e.g.,
20 non-toxic, to cells.
The solid substrate may contain, or can be chemically
modified to contain a functional group that allows the solid
substrate to covalently bind to a bifunctional polylinker.
Examples of material that can be used as solid substrates
25 include glass, peptide polymers (e.g., collagen), HA-collagen hydrogel, peptoid polymers, pol~saccharides(including ~ ~ m m e r c i abeads,
l
e.& SI3PHADEX and the like),
carbohydrates, hydrophobic polymers, polymers, tissue culture polystyrene, planar lipid layers, planar lipid bila~ers,
30 metals, derivatized plastic films, glass beads, plastic beads,
alumina gels, magnetic beads, nitrocellulose, cellulose,
nylon membranes, cotton, and glass wool.
DETAILED DESCRIPTION OF THE
The term "bifunctional agent" is used interchangeably
INVENTION
with "bifunctional cross-linker" and is a compound that
Before the present methods and compositions are 35 comprises two chemically reactive groups such as a thiol, an
amine, aketone, or an aldehyde, or a pair of binding Partners
described, it is to be understood that this invention is not
such biotin-streptavidin, biotin-avidin, antibody-antigen,
limited to particular methods, compositions, and experimenand receptor-ligand. Particular bifunctional cross-linkers are
tal conditions described, as such methods and compounds
exemplified in FIG. 6. Bifunctional cross-linkers are used in
may vary, ~t is also to be understood that the terminology
used herein is for the purpose of describing particular 40 the present invention in one embodiment to covalently bind
a ~ ~ l ~ l i ntok ae rsupport substrate, in which one end of the
embodiments only, and is not intended to be limiting, since
the scope of the present invention will be limited only the
bifunctional cross-linker is covalently attached to a reactive
group on the substrate and the other end is covalently bound
appended claims.
As used in this specification and the appended claims, the
to the polylinker. See FIG. 5 as an example of modification
singular forms
and "theminclude plural references 45 of the surface support and DNA tethering or immobilization.
The terms "polylinker" or "accessory molecule", are used
unless the context clearly dictates otherwise. Thus for
herein interchangeably to define a polymer or other cationic
example, references to
polylinkermincludes mixtures of
such polylinkers, reference to ''the formulationm or "the
compound that can act to complex with and condense the
method'' includes one or more formulations, methods, and molecule of interest, e.g., a nucleic acid, and immobilize it
or steps of the type described herein andor which will 50 on or tether it to a solid substrate. Examples of polylinkers
become apparent to those persons skilled in the art upon
include cationic polymers, cationic ~ e ~ t i d ecationic
s,
Peptoids, or cationic compounds such as cationic lipids.
reading this disclosure and so forth.
AS used herein a "tether" is a bond that covalently or
unless defined otherwise, all technical and scientific
~~o~~-covalently
attaches an accessory molecule to the solid
terms used herein have the same meaning as commonly
understood by one of ordinary skill in the art to which this 55 substrate, either directly or through a bifunctional crossinvention belongs, ~ l ~ any
h methods
~ ~ and
~ materials
h
linker. Preferably, this bond is reversible andor can be
similar or equivalent to those described herein can be used
broken
AS used herein the term "condensed nucleic acid" is a
in the practice or testing of the present invention, the
preferred methods and materials are now described. ~ 1 1 n~cleicacid (e.g., a DNAplasmid or an oligonucleotide) that
publications mentioned herein are incorporated herein by 60 is non-covalently associated with accessory molecules
reference to disclose and described the methods andor
a
(see
below). Examples
of condensing agents include cationic polymers, cationic
in connection with which the publications are
cited.
lipids and polycations.
As used herein the term a "molecule of interest" is a
Definitions
65 molecule that is tethered to a solid support for use in the
By the term "nucleic acid", "gene", or the like, is meant
methodology disclosed by the present invention. Such molecules of interest include nucleic acids such as a DNA
a polynucleotide such as a plasmid, DNA, or RNA capable
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(preferably a plasmid), an oligonucleotide, or a modified
oligonucleotide (e.g., phosphorothioate).
As used herein the term "polyplex" refers to a nucleic acid
that is complexed with cationic polymers, such as, but not
5
limited to, polyethylenimine (PEI).
As used herein, the term "lipoplex" refers to a nucleic acid
that is complexed with a lipid, such as, but not limited to, the
cationic lipid Lipofectamine 2000.
As used herein, immobilizing a nucleic acid to the cell
culture substrate prior to cell seeding has been termed 10
"substrate-mediated delivery" or "solid phase delivery".
"NIP" refers to the ratio of nitrogen to phosphorous.
used herein, the term
mediam refers to
growth media collected from cells having been in culture for
at least 24 hours. The particular cells from which culture 15
media was
in the present studies were ~ 1 ~ 1 3
cells.
used herein,
of the support substratem
may be defined as any alteration in the surface characteris20
tics of the substrate which may affect binding of the
such modifications may be chemical modifications
such as the covalent or non-covalent interactions described
herein. Alternatively, the modifications may refer to nonchemical modifications that affect the binding of the
plexes to the substrate. For example, the use of serum for 25
modifications of the substrate may have a two-fold effect. In
one case, the nitrogens from the proteins present in serum
may alter the binding characteristics of the complex to the
substrate, ~ l t ~ ~ the
~ serum
t i ~may
~ l ~ , the surface
of the substrate by altering the wettability, which in turn may 30
affect the binding
of the complexes to the
substrate.
General Description
One aspect of the invention provides a nucleic acid~ o l ~ l i n kcomplex
er
immobilized or tethered to a supporting
substrate or scaffold, wherein a cell adhered onto the supporting substrate is capable of internalizing the nucleic acid
complex and expressing the protein enc~dedby the nucleic
acid.
The approach involves forming a mn-covalent binding
complex between the nucleic acid and the polylinker molecule. The polylinker molecules are b ~ u n dto the solid
substrate. The tethering of the complex serves to localize the
nucleic acid to the surface, thus placing it directly into the
cell microenvironment.
The invention also provides for characterization of gene
transfer by DNA complexes adsorbed to tissue culture
polystyrene and biomaterial substrates. Polyplexes and
lipoplexes were adsorbed to either unmodified (PS) or
serum-adsorbed (FBS-PS) polystyrene. Complex immobilization to the substrate increased with time of exposure, and
the deposition rate and final amount deposited depended
upon the properties of the substrate and complex.
Polyplexes immobilized to FBS-PS provide greater transfection than polyplexes immobilized to PS, and equivalent
or greater transfection than "bolus" delivery of complexes,
wherein the delivery of the nucleic acid complexes to cells
is accomplished all at one time. Moreover, there is greater
cytotoxicity associated with bolus delivery as compared to
the substrate-mediated approach. Lipoplexes, however, provide similar levels of transgene expression on serum coated
and uncoated surfaces. Interestingly, transfection on serum
coated surfaces increases the number of transfected cells
relative to uncoated surfaces. Immobilized complexes are
able to transfect primary cells, and result in lower cytotoxicity relative to bolus delivery. Finally, this delivery mecha-
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nism can be adapted to biomaterial surfaces, such as PLG,
which is commonly used for biomedical applications such as
tissue engineering.
Reverse transfection and substrate-mediated delivery are
based on the immobilization of DNA complexes to the
culture substrate, which has been achieved by several methods. Ziauddin and Sabatini deposit naked DNA followed by
addition of a cationic lipid. Plasmid DNA is suspended in
gelatin and spotted onto a slide, which is followed by lipid
addition to the culture media. Substantial transfection of
HEK 293 cells was observed using this approach (Ziauddin
and Sabatini 2001, Nature 411(6833): 107-lo), and may
require some modification to transfect other cell types
(Bailey et al. 2002, Drug Discov Today 7(18 Suppl):S113-8;
WU et al. 2002, Trends Cell Biol 12(10):485-8).
~ A"
3 alternative to the DNMgelatin immobilization procedure involves the complexation of plasmid with cationic
lipids or polymers, which are then immobilized to the
substrate. Biotin residues have been attached to cationic
polymers, which are then mixed with plasmid to facilitate
specific binding of DNA complexes to an avidin-modified
substrate (Segura and Shes 2002, BioconJug
13(3):
621-9; Segura et al. 2003, J Control Release 93(1):69-84).
Increasing the number of biotin residues enhanced substrate
binding, whereas maximal transfection of ~ ~ ~ and
2 9
N1H13T3
was
with few mmbers
residues. However, complexes can be non-s~ecificall~
adsorbed to the substrate, likely through interactions
between the cationic lipid or polymer and the substrate.
Complexes have been formed in the Presence of extracellular matrix components and dried onto the substrate
(Yoshikawa et al. 2004, J Control Release 96(2):227-32).
This approach transfected a variety of cell types, including
human mesenchymal stem cells.
The present invention provides for polyplex and lipoplex
binding to the substrate from solution, and the ability to
trmsfect cell lines and primary hman-derived cells, all of
these aspects having advantages over the existing methods,
The studies presented herein have sought to characterize
properties of the substrate and the complexes that mediate
substrate immobilization and transgene expression.
Substrate immobilization of DNA complexes by adsorption results from non-covalent, nonspecific interactions
between the substrate and complexes, and can depend upon
the molecular composition of both vector and substrate.
Non-specific adsorption of proteins to surfaces has been
characterized by molecular interactions, which include
hydrophobic, electrostatic, and van der Waals interactions
(Norde and Lyklema 1991, J Biomater Sci Polym Ed 2(3):
183-202). DNA complex adsorption likely occurs through
similar mechanisms. Both lipoplexes and polyplexes adsorb
to the substrates, with at least 60% immobilized after 24
hour incubation. Substrate immobilization can prevent complex aggregation (Segura et al. 2003, J Control Release
93(1):69-84), maintain complexes at the surface during
wash steps, and may enhance complex stability.
Maximal transfection from the substrate is hypothesized
to represent a balance between complex binding to the
substrate and cellular internalization. As shown herein,
transfection was observed with both polyplexes and
lipoplexes adsorbed to serum modified and unmodified
polystyrene, suggesting that substrate-mediated delivery is
applicable to a variety of transfection reagents and substrates. However, this cellular transfection by the immobilized DNA complexes was not equivalent across substrates
and transfection reagents. Serum coating of polystyrene
could enhance transgene expression (polyplexes) or the
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percentage of transfected cells (lipoplexes). These differences in the transfection profile do not reflect substantial
differences in the amount of DNA immobilized (FIG. la),
and may result from differences in cellular internalization
from the substrate. Conditions with relatively low transfection had DNA bound to the substrate, whereas conditions
with higher transfection showed less substrate-associated
DNA and more cell-associated DNA (FIG. 22). Addition of
conditioned media to the substrates significantly enhanced
release of the complexes relative to incubation with PBS. A
cellular product, such as proteases, may promote release of
the complexes from the substrate. The mechanism of cellular
internalization from the substrate, and DNA distribution
among the cell populations are the focus of continuing
studies.
Maximal transgene expression for polyplexes and
lipoplexes by substrate-mediated delivery is similar, yet the
transfection profile and dependence on the substrate properties reflect differences in composition and intrinsic transfection properties. Polyplexes and lipoplexes have substantially different z-average diameters, zeta-potential, and
chemical composition. Increasing the NIP ratio for polyplexes increases their zeta potential and reduces their size
(Boussif et al. 1995, Proc Natl Acad Sci USA 92(16):
7297-301; Choosakoonkriang et al. 2003, J Pharm Sci
92(8):171&22; Ogris et al. 2001, AAPS PharmSci 3(3):
E21). Conversely, altering the composition of lipoplexes has
less marked effects on the complex diameter and zetapotential (FIG. 15). An increasing NIP ratio decreases binding of polyplexes to PS and has no effect on FBS-coated PS.
As shown herein, for a 2 hour deposition, polyplexes bind
more effectively than lipoplexes, with a difference of
approximately 16%. Polyplex delivery from serum-modified
substrates could increase transgene expression relative to
delivery from PS and to equivalent quantities delivered as a
bolus. However, lipoplex delivery yields similar levels of
expression across delivery methods. Interestingly,
lipoplexes increase the number of transfected cells relative
to polyplex delivery, and produce the greatest percentage of
transfected cells by delivery from serum-coated substrates.
Immobilization of DNAcomplexes by adsorption can be
extended to biomaterials for applications such as tissue
engineering. Porous PLG or collagen scaffolds have been
fabricated with encapsulated polyplexes or lipoplexes,
which have achieved substantial transfection in vitro (Cohen-Sacks et al. 2004, J Control Release 95(2):309-20;
Huang et al. 2003, J Biomed Mater Res 67A(4): 1384-92;
Scherer et al. 2002, J Gene Med 4(6):634-43) and in vivo
(Scherer et al. 2002, J Gene Med 4(6):634-43.). The presence of the cationic lipid or polymer can significantly alter
the release profile compared to plasmid DNA. The biotinavidin interaction has been used to bind both viral and
non-viral vectors to a variety of materials (Levy et al. 2001,
Gene Ther 8(9):659-67; Segura et al. In Press). Alternatively, complexes formed with polyamidoamine (PAMAM)
dendrimers have been dried onto PLG and collagen membranes coated with phosphatidyl glycerol (1-5%) (Bielinska
et al. 2000, Biomaterials 21(9):877-87). In vitro transfection
was comparable to bolus controls, while in vivo delivery
enhanced expression six to eight-fold relative to plasmid
delivery. Alternatively, plasmid DNA has also been incorporated into inorganic calcium phosphate co-precipitates
that are adsorbed onto PLGA matrices, which are mostly
released by 48 hours (Kofron and Laurencin 2004, Biomaterials 25(13):2637-43). The present invention demonstrates
the ability to adsorb complexes to PLG to obtain significant
transfection on the substrate.

Hyaluronic Acid-Collagen Hydrogels for DNA Delivery via
a Substrate Mediated Approach
Another aspect of the invention provides a substrate
mediated strategy for delivering DNA complexes from
hyaluronic acid-collagen hydrogels. Hydrogels were formed
by crosslinking HA with poly(ethy1ene glycol) diglycidyl
ether, and a topography was introduced using pattern transfer. DNMPEI complexes of varied sizes were immobilized
to the hydrogel substrate using biotidneutravidin binding
and non-specific adsorption.
Manipulating complex properties for substrate mediated
delivery can be employed to regulate the transfection profile
(number of transfected cells, transgene expression). Complex size was modulated by forming complexes in the
absence or presence of salt. Large complexes increased the
extent of transgene expression relative to small complexes,
whereas small complexes increased the number of transfected cells relative to large complexes. The aggregation of
complexes in solution has limited the ability to correlate
transfection to complex size at a specific NIP ratio (Hagstrom J E., Curr Opin Mol Ther 2000;2(2): 143-9; Ogris M,
Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E.,
Gene Ther 1998;5(10):1425-33; Ogris M, Steinlein P,
Carotta S, Brunner S, Wagner E., AAPS PharmSci 2001;3
(3):E21). Cationic polymerlDNA (e.g., DNMPEI) complexes aggregate in polyelectrolyte solutions (150 mm
NaCl) (Goula D, Remy J S, Erbacher P, Wasowicz M, Levi
G, Abdallah B, et al., Gene Ther 1998;5(5):712-7; Plank C,
Tang M X, Wolfe A R, Szoka Jr F C., Hum Gene Ther
1999;10(2):319-32; Trubetskoy V S, Loomis A, Slattum P
M, Hagstrom J E, Budker V G, Wolff J A,, Bioconjug Chem
1999;10(4):624-8), andor in solutions containing serum
proteins such as albumin, fibronectin, and fibrinogen (Ogris
M, Brunner S, Schuller S, Kircheis R, Wagner E., Gene Ther
1999;6(4):595-605; Lucas P, Milroy D A, Thomas B J, Moss
S H, Pouton C W, J Drug Target 1999;7(2):143-56; Oupicky
D, Howard K A, Konak C, Dash P R, ulbrich K, Seymour L
W., Bioconjug Chem 2000; 11(4):492-501; Xu B, Wiehle S,
Roth J A, Cristiano R J., Gene Ther 1998;5(9):1235-43).
Strategies to stabilize complex size in solution involve steric
stabilization (Ogris M, Steinlein P, Carotta S, Brunner S,
WagnerE.,AAPS PharmSci2001;3(3):E21; GoulaD, Remy
J S, Erbacher P, Wasowicz M, Levi G, Abdallah B, et al.,
Gene Ther 1998;5(5):712-7; Ogris M, Brunner S, Schuller
S, Kircheis R, Wagner E., Gene Ther 1999;6(4):595-605;
Xu B, Wiehle S, Roth J A, Cristiano R J., Gene Ther
1998;5(9):123543; Wolfert M A, Dash P R, Nazarova 0,
Oupicky D, Seymour L W, Smart S, et al., Bioconjug Chem
1999;10(6):993-1004; Toncheva V, Wolfert MA, Dash P R,
Oupicky D, Ulbrich K, Seymour L W, et al., Biochim
Biophys Acta 1998;1380(3):354-68), caging (Trubetskoy V
S, Loomis A, Slattum P M, Hagstrom J E, Budker V G, Wolff
J A,, Bioconjug Chem 1999;10(4):624-8; Adami R C, Rice
K G., J Pharm Sci 1999;88(8):739-46), and anionic polymerlDNAparticles (Trubetskoy V S, Budker V G, Hanson L
J, Slattum P M, Wolff J A, Hagstrom J E., Nucleic Acids Res
1998;26(18):4178-85; Trubetskoy V S, Loomis A, Hagstrom J E, Budker V G, Wolff J A,, Nucleic Acids Res
1999;27(15):3090-5). The increase in complex size with
time in the presence of salts andor serum proteins has been
hypothesized to result from increased inter-complex interactions, which create bridges between complexes (Hagstrom
J E., Curr Opin Mol Ther 2000;2(2): 143-9). Nevertheless,
transfection results obtained here are consistent with a
previous report showing large complexes (600 nm) achieved
up to 500 fold greater luciferase expression than small
complexes (60 nm); however, the percentage of transfected
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cells was less substantial between large complexes and small
tive protein adsorption. Although approximately 50% of
DNMPEI complexes are released in conditioned media after
complexes (Ogris M, Steinlein P, Kursa M, Mechtler K,
48 h, gene transfer at 48 h was only observed in cells that
Kircheis R, Wagner E., Gene Ther 1998;5(10): 1425-33).
The dependence of the transfection profile on complex size
were directly attached to the hydrogel substrate (FIG. 32).
has been attributed to mass transport to the cell surface, and 5 The transfection of cells cultured on the hydrogel, but not
altered endosomal release (Ogris M, Steinlein P, Kursa M,
incubated with the hydrogel, likely results from an elevated
concentration in the cellular microenvironment. For cells
Mechtler K, Kircheis R, Wagner E., Gene Ther 1998;5(10):
1425-33). For substrate-immobilization, mass transport
cultured with the hydrogel, released complexes may be
limitations are likely insignificant and thus the transfection
deactivated (e.g., aggregation) prior to cellular internalizaprofile would be affected by endosomal release. Enhanced l o tion, or mass transport limitations may minimize cellular
transgene expression for the large complexes may result
uptake (Luo D, Saltzman W M., Nat Biotechnol 2000;lX
from an increased content of DNA and PEI per complex,
(8):893-5).
which can facilitate endosomal escape and increase the
The presence of RGD peptides in the DNA complex,
probability of DNA transport to the nucleus. Furthermore,
which was hypothesized to increase cellular binding to the
these results suggest that small complexes are more effec- 1s complexes through integrin receptors, resulted in lower
tively internalized resulting in larger numbers of transfected
transgene expression than unmodified complexes. The
cells, but are not as effectively transported through the cell
modification of cationic polymers with receptor ligands such
and thus lower transgene expression. In the present invenas transferrin (Kircheis R, Kichler A, Wallner G, Kursa M,
tion, immobilization of DNA complexes to the substrate
Ogris M, Felzmann T, et al., Gene Ther 1997;4(5):409-la),
occurred through non-specific adsorption and biotin-neutra- 20 RGD (Kunath K, Merdan T, Hegener 0, Haberlein H, Kissel
vidin (NA) binding. Non-specific adsorption of proteins to
T.; J Gene Med 2003;5(7):588-99; Harbottle R P, Cooper R
surfaces occurs through a variety of interactions, such as
G, Hart S L, Ladhoff A, McKay T, Knight A M , et al., Hum
Gene Ther 1998;9(7): 103747), and galactose (Plank C,
hydrophobic, electrostatic, and van der Waals (Norde W,
Lyklema J., J Biomater Sci Polym Ed 1991;2(3):183-202).
Zatloukal K, Cotten M, Mechtler K, Wagner E., Bioconjug
The adsorption of DNA complexes likely occurs through 25 Chem 1992;3(6):533-9; Kunath K, von Harpe A, Fischer D,
Kissel T., J Control Release 2003;88(1):159-72), enhance
similar mechanisms, and is hypothesized to depend on the
molecular composition of the vector (e.g., cationic polymer)
binding and internalization for complexes delivered as a
bolus. Reduced transgene expression with ligand-modified
and substrate. Cationic polymers such as polylysine and PEI
have been used to coat tissue culture plastic for in vitro
complexes has been seen previously for complexes with a
studies, and PEIIDNA complexes interact with serum pro- 30 net positive charge (Kunath K, Merdan T, Hegener 0,
teins (Ogris M, Brunner S, Schuller S, Kircheis R, Wagner
Haberlein H, Kissel T., J Gene Med 2003;5(7):588-99;
E., Gene Ther 1999;6(4):595-605; Lucas P, Milroy D A,
Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M,
Felzmann T, et al., Gene Ther 1997;4(5):409-18; Harbottle
Thomas B J, Moss S H, Pouton C W., J Drug Target
1999;7(2): 143-56; Oupicky D, Howard K A, Konak C,
R P, Cooper R G, Hart S L, Ladhoff A, McKay T, Knight A
Dash P R, Ulbrich K, Seymour L W., Bioconjug Chem 35 M, et al., Hum Gene Ther 1998;9(7):1037-47; Plank C,
2000;11(4):492-501; Xu B, Wiehle S, Roth J A, Cristiano R
Zatloukal K, Cotten M, Mechtler K, Wagner E., Bioconjug
J. The contribution of poly L-lysine, epidermal growth
Chem 1992;3(6):533-9; Kunath K, von Harpe A, Fischer D,
Kissel T., J Control Release 2003;88(1): 159-72). For subfactor and streptavidin to EGFIPLLIDNA polyplex formation. Gene Ther 1998;5(9): 1235-43). Previous reports demstrate-mediated delivery, transgene expression decreased by
onstrated that the presence of biotin groups in the complex 40 an order of magnitude for complexes formed with 0% and
resulted in substantially increased binding to the NA-coated
75% RGD-PEI, respectively. To our knowledge, this reducpolystyrene substrate and transgene expression compared
tion in transgene expression as RGD content is increased at
a fixed NIP has not been previously reported. A reduction in
with nonbiotinylated complexes (Segura T, Shea L D.,
Bioconjug Chem 2002;13(3):621-9; Segura T, Volk M J,
transgene expression with the presence of RGD peptides
Shea L D, J Control Release 2003;93(1):69-84). AS shown 45 suggests that cellular interactions with the complex are not
herein, biotin residues have no significant effect on binding
a factor limiting transgene expression.
Reduction in transgene expression with increased RGD
to the substrate, while DNA release and transgene expression are only moderately enhanced. For release in condicontent may result from the RGD peptide affecting intractioned media and hyaluronidase, biotinylated complexes had
ellular transport or reduced complex internalization as a
an increased release (El 5%) after 8 days with no significant 50 result of multiple cellular interactions occurring per comeffect at earlier times. Transgene expression, which is anaplex, which could limit internalization. Biomaterial scaflyzed at two days, is enhanced by a factor of 2 or less with
folds that support cell adhesion and are capable of efficient
biotinylated complexes. These observations regarding in
gene delivery can provide a fundamental tool for localized
vitro binding, release, and transfection suggests that immotransgene expression, which can stimulate and direct cellular
bilization primarily occurs by non-specific interactions 55 processes that lead to tissue formation. The scaffold is
between the DNMPEI complexes and the substrate. Release
typically biodegradable, functions to create and maintain a
studies of the immobilized complexes in different release
space for tissue formation, provides a support for cell
mediums indicate that complexes are released during incuadhesion and migration, and allows integration of the regenbation, and that released complexes transfect only cells that
erating tissue with the host (Murphy W L, Mooney D J., J
are adhered to the substrate. Immobilization of DNA com- 60 Periodontal Res 1999;34(7):413-9). DNA delivery from the
plexes occurred through complexes interacting with the
scaffold frequently targets infiltrating fibroblasts, which can
substrate, which contained NA (biotinylated complexes
serve as bioreactors for the localized production of tissue
only), HA, and collagen. Hyaluronidase treatment would
inductive factors (Bonadio J, Smiley E, Patil P, Goldstein S.,
release DNA by degrading the HA backbone, the primary
Nat Med 1999;5(7):753-9). Several strategies employ biocomponent of the substrate. Alternatively, conditioned 65 materials to provide a sustained release of DNA or DNA
media contains serum proteins and other cellular products
complexes (Pannier A K, Shea L D. Mol Ther, in press.);
that could induce release enzymatically or through competihowever, DNA complexes can also be immobilized to

concentrate the DNA at the biomaterial surface and prevent
hybridizing nucleic acid, the more base mismatches with an
distribution to non-target tissues. The present invention
RNA it may contain and still form a stable duplex (or triplex,
as the case may be). One skilled in the art can ascertain a
demonstrates a strategy to immobilize DNAto hydrogels for
delivery to adherent cells, with the properties of the immotolerable degree of mismatch by use of standard procedures
bilized complexes regulating the transfection profile (trans- 5 to determine the melting point of the hybridized complex.
gene expression, number of transfected cells). The approIn another embodiment, the nucleic acid of interest is a
priate expression profile will likely depend upon the
ribozyme or triple helix molecule used to modulate the
physiological system and gene of interest. For example,
activity, expression or synthesis of the gene present in the
transplanting engineered cells that secrete low levels of
cell. Techniques for the production and use of such molvascular endothelial growth factor (VEGF) produced a l o ecules are well known to those of skill in the art.
mature vascular network, which was not observed by transRibozyme molecules designed to catalytically cleave
plantation of cells secreting high levels of VEGF (Ozawa C
gene mRNA transcripts can be used to prevent translation of
target gene mRNA and, therefore, expression of the gene
R, Ban. A, Glazer N L, Thurston G, Springer M L, Kraft P
product. (See, e.g., PCT International Publication W0901
E, et al., J Clin Invest 2004;113(4):516-27). For genes that
act intracellularly, such as tumor suppressor genes or tran- 1s 11364, published Oct. 4, 1990; Sarver et al. (1990) Science
247:1222-1225).
scription factors, the delivery system must transfect large
numbers of cells (Braddock M., Ann Med 2001;33(5):
Ribozymes are enzymatic RNA molecules capable of
313-8; Scholl S M, Michaelis S, McDermott R., J Biomed
catalyzing the specific cleavage of RNA. (For a review, see
Rossi (1994) Current Biology 4, 469-471). The mechanism
Biotechnol 2003;2003(1):35-47). The present invention
also demonstrates that immobilization enables spatial pat- 20 of ribozyme action involves sequence specific hybridization
terning of gene transfer by transfecting cells that attach and
of the ribozyme molecule to complementary target RNA,
orient along a topographical pattern. The engineering of
followed by an endonucleolytic cleavage event. The comtissue structures, such as the intricate networks of the
position of ribozyme molecules must include one or more
vascular and nervous systems, will require methods for
sequences complementary to the target gene mRNA, and
controlling the physical placement of molecular signals 25 must include the well known catalytic sequence responsible
(Saltzman W M, Olbricht W L., Nat Rev Drug Discov
for mRNA cleavage. For this sequence, see, e.g., U.S. Pat.
2002;1(3):177-86). The ability to spatially regulate gene
No. 5,093,246, which is incorporated herein by reference in
delivery on the scaffold can be employed to create spatial
its entirety.
While ribozymes that cleave mRNA at site specific recgradients in the expression of various tissue inductive factors (e.g., growth factors, matrix molecules), which are 30 ognition sequences can be used to destroy mRNAs, the use
characteristic of many developing tissues. Opportunities for
of hammerhead ribozymes is preferred. Hammerhead
spatially controlled gene delivery include directing neurite
ribozymes cleave mRNAs at locations dictated by flanking
outgrowth, or orienting cell growth for tissues such as
regions that form complementary base pairs with the target
muscle. This spatial control of cell attachment and transfecmRNA. The sole requirement is that the target mRNA have
tion can be a powerful tool with broad applicability to tissue 35 the following sequence of two bases: 5'-UG-3'. The conengineering.
struction and production of hammerhead ribozymes is well
known in the & and is described more fully in Myers (1995)
Nucleic Acids
Molecular Biology and Biotechnology: A Comprehensive
The present invention therefore utilizes condensed
Desk Reference, VCH Publishers, New York, (see especially
nucleic acids in a complex with polylinkers, wherein the
40 FIG. 4, page 833) and in Haseloff and Gerlach (1988)
polylinkers or a percentage thereof, are covalently andor
Nature, 334, 585-591, each of which is incorporated herein
non-covalently bound to the surface of the support substrate.
by reference in its entirety.
In one such embodiment the nucleic acid is a DNA molPreferably the ribozyme is engineered so that the cleavage
ecule. In a more specific embodiment, the DNAmolecule is
recognition site is located near the 5' end of the mRNA to
a plasmid. In a related embodiment the DNA molecule
45 increase efficiency and minimize the intracellular accumuencodes a protein. In another embodiment the nucleic acid
lation of non-functional mRNA transcripts.
is an oligonucleotide, and in specific embodiments, the
The ribozymes of the present invention also include RNA
oligonucleotide is an antisense molecule, a ribozyme, or a
endoribonucleases (hereinafter "Cech-type ribozymes")
triple helix molecule.
such as the one that occurs naturally in Tetrahymena therAntisense. Ribozvmes. and Trivle Helix Molecules
50 movhila (known
as the IVS. or L-19
R N A ) ; ~that
~ has
,
The antisense nucleic acids of the invention comprise a
been extensively described by Thomas Cech and collaborasequence complementary to at least a portion of an RNA
tors (Zaug, et al. (1984) Science, 224, 574-578; Zaug and
transcript of a gene, however, absolute complementarity,
Cech (1986) Science, 231, 470475; Zaug, et al. (1986)
although preferred, is not required. A sequence "compleNature, 324, 429-433; published International patent applimentary to at least a portion of an RNA," as referred to 55 cation No. WO 88104300 by University Patents Inc.; Been
herein, means a sequence having sufficient complementarity
and Cech (1986) Cell, 47, 207-216). The Cech-type
to be able to hybridize under stringent conditions (e.g.,
ribozymes have an eight base pair active site which hybridhighly stringent conditions comprising hybridization in 7%
izes to a target RNA sequence whereafter cleavage of the
sodium dodecyl sulfate (SDS), 1 mM EDTA at 65' C. and
target RNA takes place. The invention encompasses those
washing in O.lxSSCIO.l% SDS at 68' C., or moderately 60 Cech-type ribozymes which target eight base-pair active site
stringent conditions comprising washing in 0.2xSSCIO.l%
sequences that are present in the gene of interest.
SDS at 42" C. with the RNA, forming a stable duplex; in the
As in the antisense approach, the ribozymes can be
case of double-stranded antisense nucleic acids, a single
composed of modified oligonucleotides (e.g., for improved
stability, targeting, etc.) and should be delivered to cells that
strand of the duplex DNA may thus be tested, or triplex
formation may be assayed. The ability to hybridize will 65 express the gene of interest in vivo. A preferred nucleic acid
for delivery involves using a DNA construct "encoding" the
depend on both the degree of complementarity and the
length of the antisense nucleic acid. Generally, the longer the
ribozyme under the control of a strong constitutive pol I11 or
2

,
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pol I1 promoter, so that transfected cells will produce sufficient quantities of the ribozyme to destroy endogenous
mRNA encoding the protein of interest and inhibit translation. Because ribozymes, unlike antisense molecules, are
catalytic, a lower intracellular concentration is required for
efficacy.
Alternatively, the endogenous expression of an encoding
gene of interest can be reduced by targeting deoxyribonucleotide sequences complementary to the regulatory region of
the gene (i.e., the gene promoter andor enhancers) to form
triple helical structures that prevent transcription of the
encoding gene of interest (See generally, Helene (1991)
Anticancer Drug Des. 6(6), 569-584; Helene et al. (1992)
Ann. N.Y. Acad. Sci., 660, 27-36; and Maher (1992) Bioassays 14(12), 807-815).
Nucleic acid molecules to be used in triplex helix formation for the inhibition of transcription in the present invention should be single stranded and composed of deoxynucleotides, The base composition of these oligonucleotides must
be designed to promote triple helix formation via Hoogsteen
base pairing rules, which generally require sizeable stretches
of either purines or pyrimidines to be present on one strand
of a duplex, Nucleotide sequences may be pyrimidine-based,
which will result in TAT and CGC+ triplets across the three
associated strands of the resulting triple helix, The pyrimidine-rich molecules provide base complementarity to a
purine-rich region of a single strand of the duplex in a
orientation to that strand, In addition, nucleic acid
molecules may be chosen that are purine-rich, for example,
contain a stretch of G residues, These molecules will form
a triple helix with a DNA duplex that is rich in GC pairs, in
which the majority of the purine residues are located on a
single strand of the targeted duplex, resulting in GGC
triplets across the three strands in the triplex.
Alternatively, the potential sequences that can be targeted
for triple helix formation may be increased by creating a so
called "switchback" nucleic acid molecule, Switchback molecules are synthesized in an alternating 5t-3t,3t-5t manner,
such that they base pair with first one strand of a duplex and
then the other, eliminating the necessity for a sizeable stretch
of either purines or pyrimidines to be present on one strand
of a duplex.
Antisense RNA and DNA, ribozyme, and triple helix
molecules of the invention may be prepared by any method
known in the art for the synthesis of DNA and RNA

FIG. 2). Sulfo-KMUS, SPDP, SATA, SVSB, and SulfoSIAB react with primary amines at one reactive center and
sulfhydryl groups at the other reactive center. Sulfo-NHSLC-ASA contains two reactive centers that react with primary amines. The reactions at either end of this cross-linker
are independent since the reaction involving the azidosalicylamido group is activated by ultraviolet light. TFC reacts
with primary amino groups at one of its reactive centers and
activated carboxylic acids at its other reactive center. NHSbiotin, PFP-Biotin, and NHS-PC-LC-Biotin only have one
reactive center that reacts with amino groups, whereas, the
natural binding of biotin to streptavidin is employed as the
second reactive center. NHS-PC-LC-Biotin is unique
because when it is exposed to ultraviolet light it releases the
original primary m i n e containing the molecule.

molecules, as discussed above. These include techniques for
chemically synthesizing oligodeoxyribonucleotides and oligoribonucleotides well known in the art such as for example
solid phase phosphoramidite chemical synthesis. Alternatively, RNA molecules may be generated by in vitro and in
vivo transcription of DNA sequences encoding the antisense
RNA molecule. Such DNA sequences may be incorporated
into a wide variety of vectors that incorporate suitable RNA
polymerase promoters such as the T7 or SP6 polymerase
that
promoters, Alternatively, antisense cDNA
synthesize antisense RNA constitutively or inducibly,
depending on the promoter used, can be introduced stably
into cell lines.
Bifunctional Cross-Linkers
In one method of the invention, bifunctional cross-linkers
are used as first and second functional groups to immobilize
the nucleic acid-polylinker complex to the surface of the
support substrate. Bifunctional cross-linkers have two reactive centers, which are generally at opposite ends of the
cross-linker, e.g., a first and a second functional group, and
are used to bind two molecules together (see, for example,
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A ~ O 1 ~ l i n kise r
for
with the
of interest, e.g., a nucleic acid. In different embodiments, the
qolylinker is a cationic polymer, a cationic protein Or peptide, Or a cationic lipid. The polylinkers of the present
invention function to form a complex with the molecule of
interest, and
the
the surface the
The polylinker may be
bound to
substrate. In a particular
the percentthe
age of polylinkers
bound to the surface of the
solid substrate is greater than 0.2%. In another embodiment,
between 0.5-50% of the polylinkers are
bound to
the surface of the solid substrate. In a more specific embodiment, between 1.0-25% of the polylinkers are
bound to the surface of the solid substrate. In a particular
the
between the polylinker and
the solid substrate is broken after a cell is plated on the solid
substrate.
Cationic lipids: The main components of a cationic lipid
are a h ~ d r O ~ h i llipid
ic
a linker group, and a positively
headgroup. The lipid
is
either a fatty chain (e.g., derived from oleic or myristic acid)
Or a
group, which determines the physical properties of the lipid bilayer, such as flexibility and the rate of
lipid exchange. The linker group is an
determinant
of the chemical stability, biodegradability, and transfection
efficiency of the cationic lipid. Biodegradable lipids can be
metabolized by various enzymes (e.g., esterases, peptidases)
to minimize any toxicity. The linker can also provide sites
for the introduction of novel side chains to enhance targeting, uptake, and trafficking. The positively charged head
group on the cationic lipid is responsible for interacting with
the negatively charged DNA and is a critical determinant of
the transfection and cytotoxicity of liposome formulations.
The headgroups differ markedly in structure and may be
single- or multiple-charged as primary, secondary, tertiary,
andor quaternary amines. The hydrophobicity of the lipid
moiety has a crucial effect on in vitro gene transfer. Multivalent headgrou~s,such as 'permine, in a "T-sha~e"'Onfiguration tend to be more effective than their monovalent
gene transfer.
Counterparts at
increases in the linker length correspond to increases in the
gene delivery activity. Mixing of DNA and cationic lipid
results in the collapse of DNA to form a condensed structure-termed lipoplex-in which nucleic acids are buried
within the lipid. The thermodynamic driving force for association of the DNA and lipid is the entropy increase from the
release of counter ions and bound water associated with
DNA and the lipid surface.
The colloidal properties (e.g., size, stability) of the
lipoplexes are principally determined by the cationic lipid
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DNA charge ratio and not the composition of the lipid or the
helper lipid. The charge ratio (+I-) is typically defined as the
number of amines on the cationic lipid relative to the number
of phosphate groups on the DNA. A neutral charge ratio (1 :1
charge ratio for 1ipid:DNA) should generally be avoided
because it results in the formation of large aggregates (>1
pM). Lipoplexes prepared at a positive charge ratio and a
negative charge ratio likely represent structures with different lipid and DNA packaging (Xu et al. (1999) Biophys. J.
77:341-353). At a positive charge ratio, large multilamellar
vesicles (LMV, diameter 3 0 6 7 0 0 nm) transfect cells more
efficiently than the small unilamellar vesicles ( S W , diameter 50-200 nm) (Felgner et al. (1994) J. Biol. Chem.
269:25562561; Turek et al. (2000) J. Gene Med. 2:3240;
Ross and Hui (1999) Gene Ther. 6:65 1-659). The order in
which DNA and lipid are mixed is critical and significantly
affects the lipid and DNA packing (Xu et al. (1999) supra).
For the addition of DNA to lipid, a gradual increase in size
is observed. When adding lipid to DNA, the particle size
remains roughly constant until the amount of lipid positive
charge exceeds the nucleic acid negative charge, whereupon
the particles grow rapidly in size (Kennedy et al. (2000)
Biophys. J. 78: 1620-1633).
The net charge on the lipoplex affects its interactions with
other components present in vivo and in vitro (e.g., media,
serum, extracellular matrix glycoproteins, mucosal secretions), which can limit the transfection efficiency. A positive
charge ratio, which facilitates interactions with the cell
membrane, is generally prefered for in vitro studies (3:1),
whereas in vivo use may require the charge ratio to be
altered because of interactions with components of the
physiological environment. The charge ratio of the complex
determines the zeta potential, which ranges from -55 mV to
+55 mV as the charge ratio is increased. Multivalent anions
present in the serum or media can facilitate fusion of the
lipids causing an increase in the size of the particle. Polyanions with adequate anionic charge density (e.g. heparin)
released DNA from the complex by binding the cationic
lipid. Serum can be a complicating factor for positively
charged complexes, possibly causing premature release of
the DNA from the complex and enhancing degradation by
nucleases. For 0N:lipid complexes, the various components
of serum (e.g., BSA, lipoproteins, and macroglobulin) interact with the complexes and alter the complex diameter, zeta
potential, and interfere with cellular uptake and nuclear
trafficking.
To improve lipoplex stability, PEG-PE can be incorporated into the cationic liposome. Such liposomes are prevented from aggregating and interacting with serum components, which increases their stability (Hong et al. (1997)
FEBS Lett. 400:233-237; Meyer et al. (1998) J. Biol. Chem.
273: 15621-15627). Alternatively, a detergent can be placed
in solution with the cationic lipid and DNA (Hofland et al.
(1996) Proc. Natl. Acad. Sci. USA 93:7305-7309). Removal
of the detergent by dialysis allows the formation of uniform
complexes. Lyophilization can also increase their shelf life.
Cryoprotectants (e.g., sucrose, trehalose) also can be added
to prevent aggregation and fusion of plasmidllipid complexes during lyophilization.
Formulations of cationic lipids have been widely applied
for in vitro nucleic acid transfection (see, for example,
Felgner et al. (1987) Proc. Natl. Acad. Sci. USA
84:7413-7417) and more than 30 products are commercially
available for this purpose, including Lipofectin (a 1:1 mixture of DOTMA and DOPE), Transfectam, Lipofectase,
Lipofect-AMINE, and LipoTaxi. Formulations of cationic

lipids can further contain a zwitterionic or neutral colipid,
such as DOPE or cholesterol, to enhance transfection.
Cationic Polymers: All cationic polymers contain high
densities of primary amines, which are protonatable at
neutral pH. This high density of positive charges allows the
cationic polymers to form stable complexes with non-viral
DNA. The cationic polymers self-assemble with DNA to
generate condensed structures (46100 nm in diameter)
capable of entering the cell. Cationic polymers include
polyallylamine, peptoids, methacrylamide, and cyclodextrin
containing polymers. Such polymers vary widely in their
structure, which ranges from linear to highly branched
molecules and influences their complexation with nucleic
acids and their transfection efficiency. In addition to providing positive charges for DNA complexation, the primary
amines also serve as functional groups with which to chemically modify the polymers with ligands and peptides that can
enhance one or more of the steps in the transfection process.
Poly-L-lysine (PLL) and poly-L-omithine are the most
commonly used cationic polymers for gene delivery. Differing in chemical structure only by the length of their side
chain (4 versus 3 carbons), they are capable of mediating
gene delivery both in vitro and in vivo (Duguid et al. (1998)
Biophys. J. 74:2802-2814). In order to form uniform complexes, these polymers are generally synthesized on a solid
support using a series of protectingide-protecting synthetic
steps (e.g. Fmoc chemistry) to obtain mono-disperse peptides. PLL is typically used at charge ratios (+/-) ranging
from 3:l to 6:l. The ideal length of the PLL represents a
balance between two competing effects: effective condensation and cytotoxicity. Relative to low molecular weight,
the high molecular weight PLL forms tighter, smaller condensates that are more resistant to the effects of salt concentration and sonication [Adami et al. (1998) J. Pharm. Sci.
87: 678-683). However, cytotoxicity has been found to be
inversely related to particle size (Duguid et al. (1998) supra),
likely due to the high molecular weight PLL.
Poly(ethy1enimine)(PEI) has been widely used to mediate
gene delivery due to its high cationic charge density resulting from the protonatable amine on every third carbon. PEI
can be synthesized by the acid catalyzed ring opening
polymerization of aziridine as either a linear or a branched
structure. Similar to the PLL complexes, low molecular
weight PEI is less cytotoxic than high molecular weight PEI.
Furthermore, PEIIDNA complexes must also bear a net
positive charge (6-13: 1+/-ratio) in order to efficiently transfect cells (Boussif et al. (1995) Proc. Natl. Acad. Sci. USA
92:7297-7301; Fischer et al. (1999) Pharm. Res.
16:1273-1279, Goula et al. (1998) Gene Ther. 5:712-717).
The presence of sodium chloride during complexation can
result in particles with amorphous shapes and diameters
greater than 1 pm.
Dendrimers are an attractive architecture for gene transfer
because their well-defined structure and robust chemistry
enables the synthesis of many generations of protonatable
amines. Starbust dendrimers such as polyamidoamine dendrimers (PAMAM) are capable of mediating gene delivery
(Fischer et al. (1999) supra; Bielinska et al. (1997) Biochim.
Biophys. Acta 1353:180-190; Qin et al. (1998) supra).
PAMAM can be synthesized from either an ammonia or
ethylenediamine core by successive addition of methyl
acrylate and ethylenediamine (Tomalia et al. (1990) Angew
Chem. Int. Ed. Engl. 29:138-175). The surface charge and
diameter of the dendrimer is determined by the number of
synthetic steps (i.e. number of generations). The generation
of PAMAM used to complex DNA determines particle size
and transfection efficiency. At charge ratios (+I-) above or
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equal to one, no free DNA is observed. Higher levels of
molecule with the substrate. Alternatively, the solid substrate
itself may degrade to release the molecule of interest.
transfection are observed for PAMAWDNA complexes
In one particular aspect, the method of the present invenformed from generation 5 and 6 dendrimers than with lower
tion spatially controls gene delivery to cells within prePAMAM generations [Fischer et al. (1999) supra).
defined
On a
substrate. A DNA sequence
Cationic polymers can also be used in combination with
encoding for a specific gene, for example, is localized to a
~iposomes,DNA is initially complexed with PLL at low
charge ratios and cationic lipids are subsequently added to
distinct
On a
(e.g., a glass
for
Internalization of the
completely condense the DNA, ~
l
~ the
~ PLL
~ con~
~ to~cellsi cultured
~
~within
l that
~ domain.
,
densed DNA containing a net positive charge can subseDNA
the
a
gene
quently be complexed with an anionic lipid, precondensa- 10 within each domain. Thus, an array of cells is created in
which gene expression varies between domains.
tion with polylysine has been shown to reduce serum
genes can be used quantify the effectiveness
inhibition and also enhanced the transfection efficiency
(Mtiello et al. (1996), Gene Ther. 3:396-404; Gao and
gene
genes
the quantification
the spatial location of protein production and the quantity of
Huang (1996) Biochemistry 35:1027-1036).
15 protein produced. A plasmid encoding for green fluorescent
Control of DNA Delivery to Cell
protein (GFP) for example, may be used to follow expresnenucleic acid may be internalized directly from the sion in the cell population cultured on the surface over time
Using a fluorescence microsco~e(see the examples below).
surface since each nucleic acid molecule is complexed with
The quantity of protein production also can be quantified
many acessory molecules and only a fraction of them are
tethered. Alternatively, the tethers linking the complex to the 20 Using the reporter gene luciferase, which is assayed with a
luminometer.
surface may be broken, thus releasing the entire complex as
Uptake of the complex can be tracked by attaching a label
a soluble factor into the immediate cellular microenviron(e.g., a fluorescent tag) to the molecule of interest or to the
ment for internalization. This system also provides the
tether~ol~linker.
The labeledn~~lecule
could be followedb~
potential to spatially and temporally control gene delivery to
cells on the scaffold, spatial control is obtained through 25 fluorescence microscopy to determine if it has been interregulating the location where the DNA is tethered to the
nalized or acted Upon by the cell. Labeling the tether
surface. Temporal control is obtained through the number of
~ ~ l ~ l i n with
k e r one fluorescent tag and the molecule of
tethers used in localizing the DNA complex to the surface.
interest with a different tag may be Used to follow the
Release of the complex into solution or uptake by cells may
position and timing of each component separately.
not occur if few tethers remain; thus, the timing of release 30
The technique of tethering DNA to adhesive surfaces for
or uptake can be regulated through the number of tethers that
d ~ a n c e dgene transfer has additional applications for in
must be broken, ~h~ surface density of DNA, the number
vivo gene delivery and tissue engineering. Tethering of DNA
and type of tethers, the properties of the scaffold, and the
to the surface of a solid SupPo* (e.g., polymer, glass)
design of the polylinker are major design criteria that affect
increases cellular Uptake by placing the DNA directly at the
35 cell surface, thus overcoming many mass transfer limitations
release and uptake.
associated with gene transfer. Cells will adhere to the
The number of tethers can be used to regulate how tightly
material
surface to which the DNA is tethered. Additionally,
a molecule of interest is associated with the solid support,
the tethering provides for a technique to
which
Fewer tethers can allow for a quicker release or uptake of the
access
to
the
DNA
and
for
regu1ated
molecule of interest, whereas more tethers can delay the
40 gene delivery.
release or increase uptake time.
In the present invention, controlled gene delivery and
The tethers or the bifunctional cross-linkers of the present
expression is achieved by sequestering DNA to specific
invention can either be transient, that is a tether that they can
locations, using techniques that still allow for internalization
be designed to break or be broken after a certain desired time
and expression, The strategy, shown in FIG, combines the
frame, Or
can be designed to be
such 45 techniques of protein
DNA packaging, and susas a protein which is
proteolytic enzymes, Or
tained release, In one example of the method of the invenalternatively, the tether can be relatively stable such a plastic
tion, plasmid DNA is initially complexed with multiple
or nylon.
types of cationic peptides in a process known as DNA
In the case of a transient tether, the freeing of the molecule
condensation~a process designed to enhance cellular
of interest can be effected by hydrolysis, in which the tether 50 uptake and nuclear trafficking, Hundreds of cationic pepdegrades slowly with time in the Presence of water. In
tides bind to each plasmid. A fraction of these peptides are
another embodiment, the tether is sensitive to an outside
subsequently tethered to a support substrate using techstimulus such as light, free radicals, radiation, etc., thereby
niques established for controlled protein delivery. A support
being degraded by the stimulus and releasing the n ~ ~ l e c u l e substrate can be glass or plastic, but for in vivo gene delivery
of interest. One example of a transient cross-linker, is a 55 and tissue engineering is more preferably a biocompatible
protein that can be enzymatically cleaved causing the molsolid substrate such as collagen or alginate, or a polyethylecule of interest to be released. The enzymes catalyzing the
ene glycol (PEG) based hydrogel. The tethering results in
bond-breaking reaction may be secreted by the cells or
DNA being localized ionically at the surface of the support
alternatively may be present in the extracellular space.
substrate by the covalently bound peptides. The peptides
The case of a permanent tether or cross-linker, the mol- 60 function to package the DNA for efficient transfection while
ecule of interest would not be released as a soluble factor
the substrate surface localization maintains the DNA in the
into the media, but would have to interact with the cell
cell microenvironment for extended times, thus providing
directly from the substrate surface. If the molecule of
prolonged opportunities for internalization. The optimal
interest needs to be internalized, the cell would have to pull
number of tethers represents a balance between competing
the molecule away from the components that link it to the 65 effects. If no tethers are present, the DNA is free in solution
surface; thus, the strength of interaction of the molecule with
to be internalized, but spatial control cannot be achieved. If
the cell would need to be greater than the interaction of the
every peptide is a tether, internalization may not be possible
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because of the strong ionic interaction between the DNA and
the peptide. Therefore, the amount of tethering of the DNA
to the support substrate will vary with application. This can
be achieved forming DNA
that are tethered
the "lid
with varying number of tethers. For
can be seeded Onto the 'lid
and
examined for their ability to internalize and express a given
gene. The optimal number of tethers to employ is therefore
readily determined by testing this
for any
desired application.
Another consideration is that the number of tethers can be
designed to decrease with time, either through the action of
proteases or through a degradable linker. The appropriate
tethering serves to maintain the DNA at the surface for
internalization either by receptor-mediated endocytosis
which pulls the DNA from its ionic interaction with the
tether or by degradation of the tethers which i-ekases the
DNA complex into solution in the cell microenvironment.
Cell Culture
cells seeded onto the solid substrate can be cultured in
vitro to ultimately produce tissues or portions of tissues for
tissue transplantation. The culturing of cells on the solid
substrate can be performed by placing the cell/solid substrate in a medium that contains the necessary factors for cell
survival. The cell/solid substrate is subsequently placed in a
37" C. incubator, that may have controlled humidity and
Oxygen
is performed
in a bioreactor which acts to
regu1atethe temperature,
Oxygen and nutrient
for 'ptimal
growth On the
solid substrate.
The present invention also provides methods for preparing tissue ex viva, One such embodiment comprises seeding
a cell on a solid substrate of the present invention and
culturing the cell in a medium that contains the necessary
factors for survival, a particular embodiment the cell is a
native progenitor cell. In another embodiment the cell is a
transplanted stem cell. In a particular embodiment the cell is
an osteoblast. In yet another embodiment, the cell is a
hematopoietic stem cell. In still another embodiment, the
cell is a hepatocyte. In yet another embodiment, the cell is
an embryonic stem cell. In a particular embodiment the
condensed nucleic acid of the solid substrate had been
delivered in a spatially controlled pattern to the solid substrate. In a preferred embodiment, the condensed nucleic
acid comprised by the solid substrate encodes a protein that
directs tissue formation. In a particular embodiment of this
type, the protein is a growth factor. In an alternative embodiment the protein is a cytokine. In still another embodiment,
the condensed nucleic acid comprised by the solid substrate
encodes a transcription factor. In Yet another embodiment,
the condensed nucleic acid comprised by the solid substrate
encodes at least two of the following: a growth factor, a
transcription factor and a cytokine.
Applications
Tissue engineering aims to create functional tissue
replacements for patients suffering from organ loss or tissue
failure. To achieve this objective, these tissues will develop
from native progenitor cells or transplanted stem cells on a
synthetic scaffold that mimics the natural environment.
Controlled gene delivery allows spatial variations in gene
expression enabling the organization of multiple cell types
within a tissue (e.g., nerve cells surrounded by supporting
Schwann cells) or provide a directional signal (e.g., neurite
extension). Temporal patterns regulate the switching of cell
function from an immature to a mature stage. For example,
during bone development, osteoblasts switch from an initial
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proliferation stage to a final mineralization stage. By means
of controlled gene delivery, tissues could be engineered by
incorporation of appropriate signals into a support scaffold.
A, application of spatially controlled gene delivery is
nerve regeneration, Neurite extension is guided by gradients
in various factors (e.g., NGF, netrins). Spatially controlled
expression of these genes can be used to create these
concentration gradients. The number and orientation of
neurites in response to the chemical gradients are quantified
measures of the
An application of temporally controlled gene delivery is
bone development, which has been characterized by three
stages. The expression of stage-specific genes is examined
for effects on mineralized tissue formation. A gene encoding
for a growth factor (e.g., TGFfl) is delivered early to increase
cell density while a second gene (e.g., osteocalcin) is delivered later to enhance mineralization, cell density, mineralization, and bone-specific gene expression are used as measures of tissue formation. These applications demonstrate
the potential of this approach, which has additional application to numerous cell systems.
The present invention also provides methods of determining the effect of gene expression on cell function, A particular method ofthis type comprises adding a c e l ~to a well
of the ,icrotiter plate comprising multiple wells in which
the wells contain condensed nucleic acids encoding a protein, The function of the cell is then monitored, The effect of
the expression of the protein encoded by the condensed
nucleic acid on cell function is then determined. In another
the
are then
for a desired effect, for
decreased resistance a
The DNA
encoding the protein causing the
response can be identified based on its location in the array.
Similar approaches could be used using arrays of antisense
oligonucleotides;for example, by preparing D N A ~ o l ~ l i n k e r
complexes with different DNAs of u ~ ~ h o w
function,
n
tethering the complexes to a solid support in a microarray
format, and adding cells to in an array, cells plated on the
array would then be assayed for their ability to respond to
certain stimuli. In this manner, one could identify important
targets for pharmaceutical intervention (e.g., through the use
Of
compositions comprised of antisense oligonucleotides or other molecules inhibiting the expression
activity ofthe target), l-he invention also provides a
tool for research; e,g,, by selectively inhibiting the expres,ion of different proteins involved in intracellular signaling,
One could identify the signaling pathways involved in a
cellular response to a stimulus. It is anticipated that the cell
function assays ofthe present invention can be adapted into
a format suitable for high-throughput screening,
The present invention further provides methods for regenerating tissue at the site of a wound. In one embodiment, the
method comprises contacting a solid substrate of present
invention with a cell at the site of the wound. In a preferred
embodiment of this type, the condensed nucleic acid comprised by the solid substrate encodes a protein that directs
tissue formation. In a particular embodiment of this type, the
protein is a growth factor. In an alternative embodiment the
protein is a cytokine. In still another embodiment, the
condensed nucleic acid comprised by the solid substrate
encodes a transcription factor. In yet another embodiment,
the condensed nucleic acid comprised by the solid substrate
encodes at least two of the following: a growth factor, a
transcription factor and a cytokine.
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Creating Spatial Patterns for Expression of the Nucleic Acid
Spatial patterning of genes onto surfaces can be performed using a multitude of methodologies. For example, an
arrayer may be used to place a specified volume onto a
specific spot on the solid substrate, An arrayer is currently

In a particular embodiment of the present invention a
Support surface is employed that has the ability to gel upon
implantation into the body (Elisseeff et al. (1999) Plast
Reconstr Surg, 104:1014-1022). Implantation of the material results in gelling and filling of the desired space. Cells
from the surrounding tissue would then interact with the
material and would be presented with the molecule of
interest to direct its action, such as for regeneration of a
tissue (i,e,, tissue engineering),
of an immune
response (e,g,, cancer therapies), secretion of a therapeutic
molecule (i,e,, drug delivery), or any other desired cell
function.
Example 1 below describes experiments examining tethering complexed polylysine (PLL)IDNA on glass slides,
surface densities achieved. and use in cell transfection,
Example 2 describes the synthesis of biotinylated PLL
and complexation with DNA. Polylysine was covalently
modified with biotin residues either through an N-terminal
cysteine side chain (K,,) or through an
(K,,,), HPLC
analysis of the initial peptide (K,,) and the peptide reaction
mixture (K,,-B) demonstrated that the reaction proceeded to
completion (FIG, 71, as evidenced by the increase in
molecular weight in the reaction mixture and the absence of
the lower molecular weight K,, peak, M~~~spectrometry
(FIG, 8) suggests that the approach for modifying the
peptide K,,
in the attachent o f a single biotin group,
A good correspondence was found between the theoretically
expected molecular weight for K,, modified with a single
biotin (3158 D ~ )and
, the experimentally obtained molecular
weight (3157,6620.77 Da). Alternatively, the chemistry
employed for modification of K,,, allows for multiple biotin
residues to be attached per PLL. The K,,,-B synthesis
resulted in a 3.1:l molar ratio of biotin to K,,, by using a
10:1 molar ratio of biotinylation reagent to K,,, in the
reaction mixture.
As described in Example 3, the synthesized biotinylated
and non-biotinylated peptides were subsequently analyzed
for their ability to complex with DNA using gel electrophoresis. The non-biotinylated peptides (K,,, K,,,) completely eliminate the electrophoretic mobility at charge
ratios of 3.1 and 1.2 respectively (results not shown).
However, the presence of the biotin group on the peptide
affected the charge ratio at which the mobility is eliminated,
which is 4.6 and 4.9 for K,,-B and K,,,-B respectively.
Mixtures of K,,,-B with K,, were also examined by gel
electrophoresis for DNA complexation at a charge ratio of
5.5:l. The inhibition of mobility was observed for all
combinations of the two peptides. The results illustrate that
the biotinylated peptides, non-biotinylated peptides, and
mixtures of biotinylated and non-biotinylatd peptides are
capable of electrostatically neutralizing plasmid DNA and
eliminating its electrophoretic mobility.
The availability of the biotin groups on the PLL for
tethering to a surface was determined using the affinity of
biotin for neutravidin (non-glycosylated avidin). Surfaceassociated DNA was visualized for DNA complexed with
K,,,-B. Fluorescence images taken after the initial incubation on the surface and before the wash demonstrates the
presence of complexes across the entire surface (results not
shown). Thorough washing of the surfaces resulted in a
reduction of the quantity of surface-associated DNA. All
subsequent studies used surfaces that were thoroughly
washed to ensure binding specificity of the complexes.
The quantity of surface associated DNA was subsequently
measured as a function of the PLL peptides and the number
of biotin groups per complex. Non-biotinylated peptides
used for DNA condensation resulted in low surface densities

being employed to spatially
oligonucleotides for
gene chips. Alternatively, microfluidics technology can be
used to specifically deposit a liquid containing DNA onto a
'pecific region of the "lid substrate. In yet another embodiment, the solid substrate can be chemically modified using
any of a variety of photolithography techniques.
Specific Embodiments
Thus the present invention combines DNA condensation
with polymeric delivery to tether DNA complexes to a
surface (FIG. 11, to which cell adhesion can be controlled.
DNA is ionically complexed with a cationic peptide to
stabilize against degradation and to enhance uptake. A
fraction of the cationic peptides that package the DNA are
subsequently tethered to the surface of a support substrate,
thus maintaining the DNA at the surface through an ionic
interaction. The linkages can be designed to be temporary,
either through enzymatic degradation of the bifunctional
crosslinker or through a reversible tether. The mechanism of
uptake may be direct internalization of the plasmid from the
surface (e.g., few tethers Per complex) or may follow
complete degradation of the tethers or bifunctional
crosslinkers, which would release the plasmid directly into
the cell microenvironment. Controlled delivery and uptake
Occurs through variations in the type and number of tethers
per plasmid.
One important aspect of the present invention is based
upon the efficient and spatially controlled delivery of nucleic
acids to cells cultured on a slide. By themselves, plasmid
DNA and oligonucleotide are not efficiently internalized by
cells and delivery cannot be spatially controlled; however,
packaging the nucleic acids into complexes can overcome
these limitations. Complexation with a cationic polymer
(e.g., poly-L-lysine, PLL)-a
process termed condensation-produces a particle with size ranging from 4 6 1 0 0
nm, a size readily internalized by cells (Mahato et al. (1999)
Adv. Genet. 41:95-156). These condensates can contain
fusogenic peptides or nuclear localization signals or may be
functionalized with receptor ligands to enhance targeting,
internalization, and intracellular trafficking of the complex
(Cristiano and Curie1 (1996) Cancer Gene Ther. 3:49-57).
The desired spatial control over delivery is obtained by
combining DNA complexation with spotting technology and
localized drug delivery. Following condensation, plasmids
and oligonucleotides are spotted into domains (106500 pm)
on a slide using, for example, the Aemetrix Pin and Ring.
The nucleic acid condensate is retained within the domain
by subsequent tethering of the complex to the surface using
a bifunctional cross-linker (FIG. 2). One functional group on
the cross-linker is coupled to a fraction of the cationic
polymers that condense the nucleic acid. The remaining
functional group on the bifunctional cross-linker reacts with
functional groups on the surface, thus tethering the complex
to the surface. The nucleic acid is maintained ionically at the
surface for direct delivery into the cell microenvironment.
Sustained plasmid delivery from surfaces that support cell
adhesion has demonstrated an increased uptake and expression (Shea et al. (1999) supra), likely due to high concentrations at the cell surface (Luo et al. (2000) supra) and
prolonged exposure to the plasmid, which provides multiple
opportunities for internalization.
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( ~ 0 . 1pg DNA/c~')due to non-specific adsorption. The use
The expression levels of protein at 96 hrs by cells cultured
on DNA-modified surfaces increased relative to the that
of biotinylated peptides for DNA complexation increased
the surface density of DNA relative to the condition of no
observed at 48 hours and, for all biotinylated DNA complexes, was greater than that obtained by bulk delivery.
biotin groups (pe0.05), suggesting that biotin groups are
available on the DNA complexes for interactions with the 5 Maximal expression levels by HEK293T cells was obtained
surface-associated neutravidin. The maximal amount of surfor the complexes containing 28 biotin groups and was
face-associated DNA was observed for DNA complexes
statistically significant from all other conditions tested
(pe0.05) (FIG. 13). The expression level decreased as the
formed solely with biotinylated peptides (pe0.001), with
average number of biotin groups on the complex increased
densities of 2.9 and 4.3 pg DNA/cm2 obtained for K,,,-B
and K,,-B respectively (FIGS. 9-10). Complexes formed l o (pe0.05). The complexes formed with K,,,-B (1705 biotin
from either K,,,-B or K,,-B were calculated to have an
groups) had the lowest transfection level of the surface
average number of biotin groups equal to 1705 and 4342
associated delivery; however, the expression level was sigrespectively. These surface densities correspond to a tethernificantly greater than the bulk control (pe0.01). The expresing efficiency (mass DNA on surfacelmass DNA added) of
sion levels for the NIHl3T3 cells were less dependent on the
24% (K,,,) and 35% (K,,). For the K,,,-B and K,,-B, 1s number of biotin groups, yet the decreasing expression
decreasing the amount of DNA incubated on the surface was
levels for increasing numbers of biotin groups was again
found to decrease the amount of surface-associated DNA
observed (FIG. 14). For all conditions tested with surface
(data not shown). The quantity of surface-associated DNA
associated delivery of DNA complexes tethered to the
was also found to decrease as the number of biotin groups
surface with biotin groups, an increased level of transfection
in the DNMPLL complex decreased. The molecular weight 20 was observed relative to the delivery of non-biotinylated
of polylysine, both biotinylated and non-biotinylated also
DNA complexes and the bulk delivery of DNA complexes
(pe0.01).
affected the quantity of surface-associated DNA. For the
biotinylated peptide K,,,-B, fewer numbers of biotin groups
EXAMPLES
were required to obtain an equivalent amount of surface
associated DNA as for the peptide K,,-B. However, the use 25
of the non-biotinylated peptide K,, for complexation
Example 1
resulted in increased DNA surface densities relative to the
Use of Tethered PLLIDNA Complexes
use of K,,,.
Culture of HEK293T and NIHl3T3 cells on the DNA
Experiment 1. Plasmid DNA encoding either green fluomodified surfaces led to cellular transfection at 48 hours, 30
rescent protein (GFP) or luciferase was complexed with
with levels of protein production equal to or greater than that
modified poly-L-lysine (PLL) at a ratio of 3.1. PLL was
obtained by bulk delivery. The transfection experiments
modified by PLL reaction with the bifunctional cross-linker
(Example 4) used mixtures of K,,,-B and K,, for DNA
6-[3'-(2-pyridy1dithio)-propionamido]
complexation because this combination had an increased
sulfosuccinimidyl
amount of surface associated DNA relative to the other 35 hexanoate (Sulfo-LC-SPDP, Pierce) prior to DNA complexpeptide mixtures, particularly when the complexes had few
ation at a 1:1 molar ratio. The PLLIDNA complexes were
numbers of biotin groups. Quantification of protein expressubsequently incubated with glass slides that were modified
sion levels for HEK 293T demonstrated that complexes with
with (3-mercaptopropy1)-trimethoxysilane (MPTS, Sigma)
28 and 426 biotin groups produced the maximal transfection
to create pendant thiol groups. Following coupling of PLLI
(FIG. l l ) , which was statistically greater (pe0.05) than other 40 DNA complexes to the slide, the surfaces were extensively
conditions with greater numbers of biotin groups. Expreswashed and treated with trypsin to degrade the PLL and
sion levels obtained for surface-associated complexes with
release the DNA into solution. The surface density of DNA
1705 and 853 biotin groups were not significantly different
was determined to be 3.920.78 pg/cm2. Control slides incufrom the control conditions, which consisted of bulk delivbated with PLLIDNA complexes without the sulfo-LCery of DNA complexes formed from either K,,, or K,,. For 45 SPDP tether had a surface density of 0.3+0.1 pglcm2 (FIG.
bulk delivery, the amount of DNA added in complexes with
3).
K,,, or K,, corresponded to the surface quantities of DNA
Experiment 2. Glass surfaces were prepared with pendant
disulfide groups by initially coupling MPTS to create penfor K,,,-B (1705 biotin groups) and K,,,-BIK,, (28 biotin
groups), respectively. These conditions were chosen as the
dant thiol groups. The thiol groups were then reacted with
control conditions to represent the limiting cases of surface 50 dipyridyldisulfide to form pendant disulfide groups on the
surface. Plasmid DNA encoding GFP was mixed for 30
associated delivery regarding DNA quantities (0.7 pg and
minutes with PLL at a charge ratio of 1:1 (positive to
0.1 6 pg) and PLL composition (K,,,, K,,). For the NIHl3T3
negative). The polylysine chains in the PLLIDNA comcells (FIG. 12), expression levels obtained by surface associated complexes with 28, 426, and 853 biotin was signifiplexes was covalently coupled to cysteine (which had a
cantly greater than that obtained with complexes containing 55 protected amino group) using EDC and Sulfo-NHS. The
PLLIDNA complex was subsequently tethered to the glass
1705 biotin residues (pe0.05). No significant difference
between complexes with 28 biotin groups and its bulk
slide through the thiol group on the attached cysteine. The
glass slides were washed to remove non-specifically bound
control (p>0.05) and 1705 biotin groups and its bulk control
(p>0.05) were found. The distribution of transfected cells
complexes. To verify attachment of the PLLIDNA comthroughout the cell population also differed between the 60 plexes, the slides were then treated with trypsin to degrade
delivery mechanisms. For bulk delivery, transfected cells
the PLL and release the DNA into solution. This quantity of
were seen throughout the cell population (not shown);
DNA in solution was measured using the Hoechst 33258
however, surface-mediated delivery resulted in cells that
fluorometric dye. The amount of DNA released into solution
were transfected in clusters. Additionally, the location of
was equal to 17.8+3.51 pg, which corresponds to a surface
transfected cells on the surface was consistent with the 65 density of 3.9320.78 (FIG. 4). The efficiency of incorporalocation of surface-associated DNA seen with the fluorestion was determined to be 13.8+2.7%. Control slides in
cently-tagged plasmid.
which cysteine was not complexed to DNA released
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0.63+0.18 pg, which corresponds to a surface density of
mine if the reaction had gone to completion. The starting
0.28+0.08 pg/cm2. The amount of DNAtethered to the slides
peptide solution and the reaction mixture were resolved by
was consistent with the amounts typically used in transfecinjecting 20 pg through a C18 RP-HPLC column eluted with
tions. The integrity of the released DNA was subsequently
water (0.1% trifluoroacetic acid (TFA)) and a acetonitrile
analyzed by gel electrophoresis and found to be intact.
5 gradient (0.1% TFA, 0 to 95% over 50 minutes at 60' C.)
NIH3T3 cells were plated into the well of the 96 well dish
while detecting the absorbance at 260 nm. For purification,
containing the tethered DNA prepared as described above.
sephadex (G15) was equilibrated in deionized water for 30
Cells were cultured at 37' C. At various times, the cells were
minutes prior to packing in a glass column (2 cm diameterx
examined using a fluorescence microscope for the expres12 cm height). The reaction mixture was passed though the
sion of GFP. Transfected cells were observed within the l o column using deionized water. Twenty fractions were colwells of the dish.
lected and the presence of the tryptophan side chain was
Experiment 3. Tethered DNA complexes were attached to
examined by measuring the absorbance at 260 nm (Beckman
96 well polystyrene microtiter plates with a streptavidin
Instruments Inc., Fullerton, Calif.). The fractions with the
coating as follows: PLL was reacted with the bifunctional
greatest absorbance at 260 nm were lyophilized (Labconco
cross-linker sulfo-NHS-LC-Biotin (Pierce) prior to DNA 1s Corp., Kansas City, Mo.) and analyzed by mass spectromcomplexing at a 1:1 or 10:1 molar ratio (Biotin:PLL),
etry. The purified biotinylated peptide (K,,-B) was stored as
generating biotinylated PLL. To form the complexes, biotia powder at -20' C.
nylated PLL was mixed with DNA at a charge ratio of 3: 1
Peptide K,,, was biotinylated using succinimide ester
and allowed to self-assemble for 30 minutes. The complexes
(NHS)/amine chemistry. K,,, (10 mg) was dissolved in 1
are formed such that the biotin groups are available for 20 mL of phosphate buffered saline (PBS, pH=7) and EZ-linkspecific coupling to a surface through a streptavidin-biotin
Sulfo-NHS-LC-Biotin (2.8 mg) was added directly to the
interaction. These complexes were subsequently incubated
solution, mixed gently and incubated for 2 hours at 4' C. The
(1-2 hours) in streptavidin modified 96-well plates. Followreaction mixture was purified using dialysis cassettes
ing coupling of PLLIDNA complexes to the wells, the
immersed in deionized water. The dialyzed product was
surfaces were extensively washed with TNBS buffer and 25 further purified using a monomeric avidin column to sepatreated with trypsin to degrade the PLL and release the DNA
rate the biotinylated components from non-biotinylated speinto solution. The number of biotin groups available for
cies. The biotinylated product was eluted with 10 ml of a 10
coupling controlled the surface density of DNA. ExperimM biotin solution and dialyzed to remove the unconjuments using 200, 100, and 50 moles biotinylated PLLImoles
gated biotin. The purified biotinylated peptide (K,,,-B) was
DNA and the 1:l molar ratio (Biotin:PLL) PLL, yielded the 30 then lyophilized and stored as a powder at -20' C. The
following surface densities: 1.16+0.01 pg/cm2, 2.54+0.05
degree of biotinylation of K,,,-B was determined by quanpg/cm2, 2.17+0.08 pg/cm2 respectively. Similar experiments
tifying the mole ratio of biotin to K,,, using 2[4'-hydroxyawith the 10:l molar ratio yielded surface densities of
zobenzenel-benzoic acid (HABA). The absorbance at 500
2.14+0.16 pg/cm2, 0.32+0.05 pg/cm2, and 0.41+0.06
nm of a HABMavidin solution in PBS was recorded before
pg/cm2. Control slides incubated with PLLIDNA complexes 35 and after the addition of the K,,,-B and used to calculate the
without the sulfo-LC-Biotin tether had a surface density of
molar ratio of biotin to K,,,.
0.06+0.02 pg/cm2.
Example 3
Example 2
Complex Formation and Surface Tethering
40
Synthesis of Biotinylated Poly-Lysine
The ability of the biotinylated and non-biotinylated polylPlasmid DNA encoding for 0-galactosidase (pNGVL1-0ysine (K,,,, K,,,-B, K,,, K,,-B) synthesized as described
gal) was purified from bacteria culture using Qiagen (Santa
above, to condense DNA was assessed by gel electrophoreClara, Calif.) reagents and stored in Tris-EDTA buffer solu- 45 sis. Biotinylated and non-biotinylated peptides were mixed
tion (10 mM Tris, 1 mM EDTA, pH=7.4). Fluorescein
and added in a stepwise manner (1 pL of 1 mg/mL) to a DNA
tagged 0-galactosidase vector (Fl-0-gal) was purchased
solution (200 pL of pg/mL). After each addition step, the
solution was vortexed for 4 seconds, incubated for 10 min
from Gene Therapy Systems (San Diego, Calif.). Two polylysine (PLL) peptides were used for DNA complexation:
and a sample (10 pL) removed. Upon complete addition of
Cys-Trp-Lyslg (K,,, BioPeptide, San Diego, Calif.) and 50 peptide, trypsin was added to digest the polylysine. Gel
LyslSo(K,,,, average molecular weight of 20,000, Sigma, St
electrophoresis was performed to assess the extent of comLouis, Mo.). Avidin and biotin reagents for peptide modifiplex formation for the samples and the trypsin-digested
cation and surface tethering were purchased from Pierce
DNA solution.
DNMPLL complexes were incubated on surfaces to spe(Rockford, Ill.). All other reagents were obtained from
Fisher Scientific (Fairlawn, N.J.) unless otherwise noted. 55 cifically tether the complexes through the biotin-neutravidin
Peptide K,, was modified with a biotin group through the
binding. DNA (90 pL of 44.4 pg/mL) was complexed at a
terminal cysteine residue by reaction of the sulfhydryl group
charge ratio (+I-) of 5.5:l with the four peptides (K,,,,
with the iodoacetyl group of the biotinylation reagent,
K,,,-B, K,,, or K,,-B) individually or with mixtures of
EZ-link-PEO-Iodoacetyl-Biotin. K,, (10 mg) was dissolved
biotinylated and non-biotinylated peptides. The number of
in 850 pL of buffer (50 mM Tris, 5 mM EDTA, pH=8.3) that 60 tethers on each complex is varied by mixing biotinylated and
was previously bubbled with nitrogen gas. The EZ-linknon-biotinylated PLLs prior to complexation with DNA.
PEO-Iodoacetyl-Biotin (3.8 mg) was also dissolved in 150
Complexes were incubated after mixing for 30 min at room
pL of buffer (0.1 M Sodium Phosphate, 5 mM EDTA,
temperature and then allowed to bind to pre-washed neupH=6.0). The biotin solution was added dropwise to the
travidin coated surfaces for 2 hours. The unbound compeptide solution, mixed gently, covered with aluminum foil 65 plexes were then removed from the wells and washed with
and incubated for 90 minutes. The starting peptide solution
tris-buffered saline (TBS). The surface quantities of DNA
and the reaction mixture were analyzed by HPLC to deterwere determined by incubating with trypsin (100 pL) at 37'
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C. for 2 hours to degrade the PLL and release the DNA into
solution. The quantity of DNA was measured with a fluorometer (Turner Designs TD-360) using the Hoechst dye.
Tethered DNA complexes were visualized by fluorescence
microscopy using the F1-0-gal vector before and after washing with TBS.

were determined at room temperature with a goniometer
(Ram&-Hart),which is equipped with a camera system and
DROPimage Standard software. A water droplet was dispensed and angle measurements were recorded as the angle
between the surface and tangent at the droplet contact with
the surface.

5

Example 4
Cell Culture and Transfection
Transfection of cells on the DNA-modified surfaces.
produced as described above, was examined using a 0-galactosidase plasmid and two cell lines (HEK293T and NIHI
3T3). Polyethyleneimine (PEI, 22 kDa, MBI-Fermentas,
Hanover, Md., 0.5 pL of 10 pM) was added to DNAmodified surfaces and incubated for 5 min. Cells were then
plated and cultured on the surfaces for 48-96 hours and then
lysed for assay of 0-galactosidase enzyme activities
(Promega, Madison, Wis.) and protein levels (BioRad, Hercules, Calif.). Alternatively, cells were stained with X-gal to
determine the location of transfected cells. HEK293T and
NIHl3T3 were cultured at 37' C. and 5% CO, in Dulbecco's
modified eagle medium (DMEM, Life Technologies, Gaithersburg, Md.) supplemented with 10% heat inactivated FBS
and 1% penicillidstreptomycin. Control experiments to
characterize the effectiveness of surface-mediated delivery
were performed by using bulk delivery of DNA complexed
with the non-biotinylated K,,, or K,,. For bulk delivery of
K,,,IDNA complexes, the quantity of DNA delivered was
determined based on the amount of surface associated DNA
obtained when DNA was complexed only with K,,,-B. For
bulk delivery of K, ,/DNA, the quantity of DNA delivered
was determined based on the amount of surface-associated
DNA obtained when DNA was complexed with a mixture of
Ki,o-BIKi9, whichhada predominance K19 over K150-B.
For the bulk delivery experiments, HEK293T and NIH3T3
cells were plated at one day prior to transfection and cultured
in complete media.
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Example 5
Gene Delivery Through Adsorbed DNA Complexes
Materials and Methods
Materials
Plasmid DNA encoding for luciferase or enhanced green
fluorescent protein (GFP) with a CMV promoter was purified from bacteria culture using Qiagen (Santa Clara, Calif.)
reagents and stored in Tris-EDTA buffer (10 mM Tris, 1 mM
EDTA, pH=7.4). Branched polyethylenimine (PEI, 25 kDa)
was purchased from Aldrich (St. Louis, Mo.). Lipofectamine
2000 was purchased from Invitrogen (Gaithersburg, Md.).
All other reagents were obtained from Fisher Scientific
(Fairlawn, N.J.) unless otherwise noted.
Surface Modification
Tissue culture polystyrene (PS) was used as provided or
after modification with fetal bovine serum (FBS-PS). Modification was characterized using X-ray Photoelectron Spectroscopy (XPS), which uses x-rays to eject electrons, which
can be measured and correlated to chemical states. XPS
spectra were recorded using an Omicron ESCAProbe system
with an AlIMf anode X-ray source. The wettability of the
surfaces was determined through measurement of the contact angle of water droplets on the surface. Contact angles
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Complex Formation and Immobilization
Addition of cationic polymers or lipids to plasmid DNA
results in self-assembly to form colloidal polyplexes and
lipoplexes, respectively. The complexing agents used were
the branched cationic polymer p~yethylenimine(PEI) and
Lipofectamine 2000. Complexes with PEI, termed polyplexes, were formed at the desired NIP (range 5-25), while
DNA complexed with Lipofectamine 2000, termed
lipoplexes, were formed at ratios of DNA:lipid (pg:pL,
range 0.5-5). For polyplexes, polymer solution (60 pL in tris
buffered saline) is added drop wise to DNA (60 pL),
vortexed, and incubated for 15 minutes at room temperature.
For lipoplexes, lipid (50 pL) is added drop wise to DNA,
mixed by gentle pipetting, and incubated for 20 minutes.
Lipoplexes were formed in serum free cell growth media.
Zeta potential and z-average diameter were measured with a
Zetasizer Nano ZS (Malvern. Worcestershire., UK).
, Complexes were immobilized by incubation on either untreated
or serum-coated tissue culture polystyrene. Polystyrene (PS,
96-well strip plate) was serum-coated (FBS-PS) by incubation with heat inactivated fetal bovine serum (200 pL, 10%
in PBS, pH=7.4) for 2 hours, followed by two wash steps
with PBS. Complexes were immobilized immediately following complex formation by incubation of DNAcomplexes
(100 pL) with the substrate for 1-24 hours, which was
followed by two wash steps.
Quantification of Immobilized DNA and DNA Release
~h~ binding and release of DNA from the substrates was
monitored using plasmid DNA radiolabeled with 32PdATP.
Briefly, a nick translation kit (Amersham Pharmacia Biotech, Piscataway, N.Y.) was used following the manufacturer's protocol with minor modifications (Segura et al. 2003).
Following immobilization and washing, complex surface
density was determined by immersing individual wells in
scintillation cocktail (5 mL, ScintiVerse 11) for measurement
with a scintillation counter. The counts were correlated to
DNA mass using a standard curve. To determine the release
profile, substrates with immobilized DNA were incubated
with PBS or conditioned media (200 pL) at 37' C. in a
humid chamber. Conditioned media was collected from
cultures (at least 24 hours) of NIHl3T3 cells. At predetermined time points, half of the solution (100 pL) was
removed and replaced with fresh solution. The activity of the
collected sample was measured in a scintillation counter. At
the final time point, the counts remaining on the substrate
were also determined. The percentage of DNA released was
calculated as the ratio of the cumulative counts released
through a given time divided by the total counts initially on
the substrate.
Cell Culture and Transfection
Transfection studies were performed with NIHl3T3
(ATCC) cells cultured at 37' C. and 5% CO, in DMEM
supplemented with 5% sodium pyruvate, 1.5 g NaHC03 and
10% FBS. Cells were seeded at a density of 5,000 cells per
well in 96-well plates. For substrate-mediated delivery, cells
were seeded immediately following complex immobilization and wash. Control studies were performed with bolus
delivery to cells plated in a 48-well dish at a density of
15,000 cellslwell and allowed to incubate overnight. The
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quantity of DNA delivered as a bolus was equivalent to the
(Table 1). The FBS treated surfaces had a low contact angle
amount of DNA immobilized to the substrate, with normal(~15') relative to the unmodified PS surface (48").
ization to the larger well. Complexes were formed as
Complex Immobilization and Stability
described above, but with a final volume of 30 pL. TransThe amount of DNA immobilized to the surfaces
fection was analyzed following a 48-hour culture.
5 .
increased with time of incubation on the surface and was
Transfection was characterized through the extent of
dependent upon the chemical properties of the surface and
transgene expression (luciferase) and the number of transDNA complex, Incubation of DNA complexes with the
fected
(GFP). The extent of transgene
was
substrate for 24 hours resulted in surface densities of at least
quantified by measuring the luciferase activity using the
pg1cm2, which corresponds to immobilization of more
Luciferase
'ystem (Promega,
Wis.).
l o than 60% of the DNA (FIG, 17A). Polyplex deposition on
were lysed and assayed for enzymatic activity after 48 hours.
pS and FBS-PS occurred at similar rates during the first
The luminometer was set for a
second
and an
hours of incubation; however, deposition onto FBS-PS
integration of the signal for 10 seconds. Transfected cells
slowed relative to PS during the final 16 hours, resulting in
were visualized and manually counted using a GFP plasmid
surface densities of 4,1 pglcm2 and 5,3 pglcm2, respecand e~ifluOrescence
(Leica, Bannockbum, Ill.) l5 tively, Lipoplex binding to the substrate was not substanwith a FITC
and
with a digita1 camera. The
tially affected by the surface properties during the 24-hour
percentage of transfected cells was calculated as the ratio of
incubation (p>0,05), The retention of complexes on both PS
the number of transfected cells divided by total cell number,
and FBS-PS substrates during incubation in PBS was unafwhich was determined by
counting of bright
fected by surface modification. For polyplexes, incubation in
20
images.
PBS resulted in 16.5% and 14.3% (p>0.05) release after 8
days from PS and FBS-PS, respectively (FIG. 17B). For
Confocal Microscopy
lipoplexes,
incubation in PBS resulted in 10.5% and 21.4%
DNA complexes were fluorescently labeled with tetramethyl rhodamine (Mirus). Polyplexes were then immobilized
b>0.05)
after
from PS and FBS-PS, respec17B). The
polyplexes gradually
followed by cell seeding. Cells were cultured for 16 hours, 25 tively
lnCreases during the 8 - d a ~
in PBS, whereas
and then labeled with the cytoplasmic stain fluorescein
l i ~ ~ ~ l ereach
x e s maximal release after 2 to 4 days. Trans&acetate (Sigma, St. Louis, Mo.). The distribution of cell
fection experiments typically involve cell culture for 24-96
and complexes on the substrate was visualized with confocal
hours,
which corresponds to release of 2.75% to 20% of
microscopy (Leica).
immobilized DNA. Increasing the quantity of DNA incu30
PLG Disk
bated with the substrate resulted in increased quantities of
immobilized DNA; however, the percentage of DNA immoThe biomaterial poly(1actide-co-glycolide)was fabricated
bilized after a 2-hour incubation is dependent upon surface
into a disk using a gas foaming process (Jang and Shea 2003;
Nof and Shea 2002). After fabrication, disks were coated
modification, and complex properties. For polyplexes
with serum and complexes were incubated with the disk for 35 immobilized to PS substrates, increasing the quantity of
24 hours as described. After washing, cells were seeded onto
DNA incubated on the surface led to a greater percentage
the disk. Transgene expression was determined using the
immobilized for all NIP ratios (FIG. 18A). Furthermore,
luciferase assay as previously described. Transfected cells
increasing the NIP ratio resulted in decreasing quantities of
were visualized by delivering a plasmid encoding for
immobilized DNA. Conversely, polyplexes immobilized to
nuclear targeted 0-galactosidase and staining with X-gal 40 FBS-PS substrates exhibited no dependence on DNA quantitles or NIP ratio (p>0.05). Lipoplex binding to PS subfollowing culture (Shea et al. 1999).
strates exhibited a dependence on DNA quantities, with
Results
lower quantities binding more effectively than higher quanComplex Formation and Surface Modification
tities, and the concentration dependence was significant for
45 FBS-PS at the lower lipid content. For both PS and FBS-PS,
The z-average diameter and zeta potential of DNA
the lipid content of the complexes did not affect the perplexes, which may impact substrate immobilization and
centage bound t' the substrate.
transfection, were measured and are consistent with published reports. The zaverage diameter (dz) of the polyplexes
Cellular Transfection
decreased with increasing amounts of cationic polymer in
Cells cultured on substrates with immobilized polyplexes
the complex, with mean diameters ranging from 1062 nm to 50 and lipoplexes were transfected and the extent of transgene
121 nm for NIP ratios of 5 and 25, respectively (FIG. 15A).
expression depended upon substrate modification, and comIncreasing the amount of cationic polymer led to increases
plex formulation. Polyplexes and lipoplexes immobilized to
in the zeta potential of ~ o l ~ ~ l e xwhich
e s , ranged from
FBS-PS substrates yielded equal or greater transgene
-14.33 mVt0 a maximum of 21.21 mV at an NIP of 10 (FIG.
expression than delivery from PS. For polyplexes immobi15B). NIP ratios greater than 10 did not significantly affect 55 lized at low densities,
the zeta potential (~>0.05).For l i ~ o ~ l e x ethe
s , mean dz
FBS-PS substrates yielded 17-fold greater transgene
ranged from 6032104 nm to 10892340 nm for increasing
expression than PS at an NIP of 25, and similar levels for
amounts of lipid (FIG. 15C). For DNA:lipid ratios greater
N/p equal to 10 (FIG, 1 9 ~ )For
. higher densities of imothan 1:2, increasing the amount of lipid had no significant
bilized polyplexes, transgene expression on FBS-PS was
effect on the zeta potential @>0.05), which averaged -50 60 increased 194-fold and 1638-fold compared to PS surfaces
mV (FIG. 15D).
for NIP equal to 10 and 25, respectively (FIG. 19B). PolyThe altered surface chemistry induced by serum coating
plex delivery from FBS-PS surfaces enhanced expression 20
was confirmed with X-ray photon spectroscopy (XPS) and
to 49-fold relative to equivalent doses delivered in bolus,
contact angle measurements. The XPS spectrum indicates
with the exception that the highest dose and NIP ratio
that nitrogen groups are present on FBS-PS, and not on PS 65 providing similar expression levels.
(FIG. 16). Serum coating also increased the wettability of
Lipoplex delivery from PS and serum-modified PS
the surfaces as determined by contact angle measurements
yielded equal levels of luciferase activity under similar
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dosage and complex conditions. At low dose conditions,
FBS-PS. Lower doses of complexes delivered as a bolus
increasing the lipid content of the complexes led to a 6.5 fold
resulted in insignificant luciferase activity (data not shown).
enhancement in luciferase activity (FIG. 19C), which was
Consistent with the NIHl3T3 culture, lipoplex delivery by
not ~bservedat the higher dose (FIG. 19D). For lipoplexes
substrate immobilization resulted in similar expression levwith the lowest lipid content and at the highest dose, an 5 els independent of surface modification (FBS-ps, ps) and
la-fold ahancement in activity was ob~ervedfrom serumthe lipid content. Additionally, transgene expression for
surfaces when
Otherpolyplexes and lipoplexes were similar; however, the perwise, transgene expression was similar between substratecentage of transfected cells using lipoplexes was approximediated and bolus delivery.
mately 26%, whereas polyplex immobilization resulted in
The similar levels of transgene expression obtained by l o
less than 5% of the cells transfected.
lipoplex delivery from both PS and FBS-PS substrates were
further examined by quantifying the percentage of trans~
~
~from a~~ i ~ ~ f~scaffold
~~ t ~~ ~ t i i~ l ~
~
fected
The percentage of transfected
was
Substrate-mediated gene delivery can be applied to subincreased nearly 2-fold on FBS-PS relative to PS, indepenstrates other than PS, which may expand the applications of
dent of quantity immobilized and the lipoplex composition 1s
this
mechanism. Pol~(lactide-co-gl~colide)
(PLG)
(FIG, 20A, B; p<0,05), Substrate-mediated delivery from
disks
were
incubated
with
P
~
~
Y
P
~
~
in
the
~ ~ ~ ,
FBS-PS resulted in similar or greater percentages of transimmobilization
of
1.3
pglcm2.
Transfected
cells
were
visible
fected cells relative to bolus delivery, Polyplexes delivered
across the substrate (FIG. 24A), and transgene expression
from FBS-PS surfaces also had greater percentages of cells
transfected compared to PS surfaces; however, transfection 20
measured at
RLU15000
seeded. These
efficiencies were low (<lo%, data not shown).
results demonstrate the potential to apply substrate-mediated
delivery to alternative substrates other than PS, including
Cell-Complex Interaction
biomaterials used in biomedical applications such as tissue
The ability of cells to promote release of complexes from
engineering,
the substrate for subsequent internalization was examined by
25
performing release studies with conditioned growth media.
summary
of ~~~~~l~ 5
In conditioned media, the release of DNA complexes was
Polyplexes immobilized to FBS-PS provided greater
greater with FBS-PS surfaces
with PS
21A)'
transfection than polyplexes immobilized to PS, and equivaAfter 8 days, 35% of polyplexes were released from PS
lent or greater transfection than bolus delivery of complexes.
surfaces and 47% were released from FBS-PS surfaces in
conditioned media, These numbers are significantly greater 30 L i ~ o ~ l e x e s ,
provide
levels
transgene
than release studies in PBS (FIG, 17B). Lipoplexes exhibOn serum coated and uncoated surfaces. Interestingly, transfection on serum coated surfaces increases the
ited similar dependence on serum coating, with 23% and
number of transfected cells relative to uncoated surfaces.
15% released from FBS-PS and p s substrates, respectively,
Immobilized complexes are able to transfect primary cells,
hi^ quantity released in conditioned media is consistent
with amount released in PBS, with the primary difference 35 and result in lower cytotoxicity relative to bolus delivery.
Finally, this delivery Inechanism can be adapted to biomabeing that maximal release was reached sooner in conditioned media. The differences in transfection observed
terial surfaces, such as PLG, which is commonly used for
such as tissue engineering.
between PS and FBS-PS were subsequently examined using
confocal microscopy to determine the relative distribution of
40
Example 6
polyplexes and cells on the substrate. Conditions with relatively low (PS) and high (FBS-PS) transfection were comDNA Delivery from Hyaluronic Acid-Collagen
pared to identify differences in the complex distribution,
(NIP 25, 2 pg incubated on the surface). Polyplexes immo~
d
~
bilized to PS, which had low transfection were distributed 45 ~ ~ ~and ~ r ~ i ~~ l h~
across the surface, with a fraction of the complexes associSodium hyaluronan (HA) was a gift from Genzyme
ated with
22A)' For
seeded Onto DNA
Corporation (1330 kDa, Cambridge, Mass.). The crosslinker
adsorbed FBS-PS substrates that yielded higher transfection,
poly(ethy1ene glycol) diglycidyl ether (CH20CHpolyplexes were not distributed across the substrate, but
(CH2CH20)n-CHOCH2, PEGDG, ~ 2 0 0 was
) purchased
were localized to the cells or their vicinity. Thus, polyplexes
50 from Polysciences (Warrington, Pa.). Adipic acid dihyhad a higher cellular association when delivered from
drazide (AAD), N-(3-dimethylpropy1)-N-ethylcarbodiimide
serum-modified surfaces than compared to unmodified surhydrochloride (EDC) and N-hydroxysulfosuccinimide
faces.
sodium salt (sulfo-NHS) were purchased from Sigma (St
Primary Cell Transfection
Louis, Mo.). Collagen was isolated from rat tails according
The ability of substrate-mediated delivery to transfect 55 to the procedure described by Choe et al. (Choe M M, Spom
primary cells was assessed using human dermal fibroblasts,
P H, Swartz M A,, Am J Physiol Lung Cell Mol Physiol,
2003;285(2):L427). Plasmid DNAencoding for luciferase or
a cell that has been difficult to transfect due to cytotoxicity.
Polyplexes delivered as a bolus resulted in large amounts of
green fluorescent protein was purified from bacteria culture
cellular debris, poor cell morphology and reduced cellular
using Qiagen (Santa Clara, Calif.) reagents and stored in
viability (FIG. 23A). For substrate-mediated delivery, the 60 Tris-EDTA buffer solution (pH=7.4). Linear PEI, biotinyfibroblasts had a morphology similar to that observed during
lated linear PEI (PEI-Biotin), and arginine-glycine-aspartypical cell culture (FIG. 23B). Transgene expression was
tic acid modified linear PEI (RGD-PEI) were purchased
greatest for fibroblasts cultured on FBS-PS, with both
from PolyTransfection (7 mm m i n e content, Strasbourg,
immobilized polyplexes and lipoplexes (FIG. 23C, 23D).
France). Neutravidin (NA) and biotin reagents for HA
Polyplexes delivered from a FBS-PS surface yielded 10.7 65 modification were purchased from Pierce (Rockford, Ill.).
fold greater luciferase expression when compared to PS,
All other reagents were obtained from Fisher Scientific
with bolus delivery producing luciferase activity similar to
(Fairlawn, N.J.) unless otherwise noted.
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Synthesis of Biotinylated-Hyaluronic Acid
HA was biotinylated by first modifying its backbone with
adipic acid dihydrazide (AAD) and then reacting the pendant hydrazide groups with sulfo-NHS-Lcbiotin (NHS-Biotin) (Segura T, Anderson B C, Chung P H, Webber R E,
Shull K R, Shea L D. Crosslinked hyaluronic acid hydrogels:
a strategy to functionalize and pattern. Biomaterials 2004; in
press). Briefly, EDC (0.5 equivalents) and sulfo-NHS (0.5
equivalents) were added as solids to the HA solution (10
mglml), followed by AAD (30 equivalents) addition. The
reaction proceeded at room temperature for 16 h with
mixing. HA-AAD was precipitated and washed in cold
ethanol. The precipitate was stored at 4' C. until use. Biotin
was introduced to HA-AAD (HA-Biotin) using NHS-Biotin.
NHS-Biotin (100 mg) was added as a solid to HA-AAD (300
mg, 3 mglml in PBS, pH 7.4). The reaction proceeded for 16
h at room temperature with stirring, and the product was
purified by ethanol precipitation.
Hyaluronic AcidCollagen Hydrogel Synthesis
HA-collagen hydrogels were formed using the reaction of
the alcohols of biotinylated HA with the PEGDG crosslinker
as previously described (Segura T, Anderson B C, Chung P
H, Webber R E, Shull K R, Shea L D., Biomaterials 2004;
in press). The hydrogels were formed with a final collagen
concentration of 0.19 mglml. A topographical pattern was
introduced into the hydrogel using a pattern transfer method.
NA was bound by hydration of the hydrogel in a 1 mm NA
solution in PBS for 1 h, followed by PBS wash.
Size and Zeta Potential Measurements
Size and zeta potential of DNMPEI complexes were
measured using a Zetasizer Nan0 Z S instrument (Malvern,
Worcestershire, UK). For com~lexation,DNA (50 ml, 40
mglml) was mixed with PEI at nitrogen to phosphate (NIP)
ratios ranging from 2.5 to 20. Complexes were formed in
either water or 150 mm NaCl in a volume of 100 ml. After
a 10-min incubation, complexes were diluted 10 times with
either water or 150 mm NaCl. To examine complex aggregation, complexes were formed in water and diluted 10
times with 150 mm NaCl, with size monitored over time.
DNMPEI Complex Immobilization
DNA complexes were immobilized to HA-collagen
hydrogels by incubation of complexes with the NA bound
HA-collagen hydrogel. DNA (50 ml of 40 mglml in 150 mm
NaCl or water) was complexed with PEI (50 ml of 150 mm
NaCl or water) at a NIP ratio of 5. Mixing biotinylated and
non-biotinylated PEI prior to mixing with DNA varied the
degree of biotinylation for the complex. The complexes
were incubated for 10 min, transferred to NA bound HAcollagen surfaces, and incubated for 2 h at room temperature. The unbound complexes were removed and the surfaces were washed extensively with PBS buffer. Surface
binding of the DNMPEI complexes was examined using
labeled DNA. Plasmid DNA was radiolabeled with a-32P
dATP using a nick translation kit (Amersham Pharmacia
Biotech, Piscataway, N.Y.) (Segura T, Volk M J, Shea L D.,
J Control Release 2003;93(1):69-84). 32P-DNMPEI complexes were formed and immobilized to the surface using the
described procedures. Following immobilization, the hydrogels were placed in scintillation cocktail (5 ml, ScintiVerse
11) and radioactivity measured with a scintillation counter.
The measured activity was correlated to DNA mass with a
standard curve. For visualization of immobilized DNMPEI
complexes, DNA was labeled with tetramethyl rhodamine
using a commercially available kit (label IT TMRhodamine,
Mirus, Madison, Wis.). Images of the complexes on HA
after extensive washing with PBS buffer were captured
using a fluorescence microscope (Leica, Bannockburn, Ill.)
equipped with a digital camera.
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DNMCationic Polymer Release
The percentage of DNMPEI complexes released from the
hydrogel was determined using 3 2 ~complexes
- ~ immo~ ~
bilized to NA bound HA-collagen hydrogels. After washing
the hydrogels, PBS (pH 7.4), conditioned media (DMEM
with 10% FBS from 2-day NIHl3T3 culture) or hyaluronidase (HAase, 100 Ulml) was added (200 ml) and the
surfaces were incubated at 37' C. in a humid chamber. The
HAase concentration was chosen to obtain significant hydrogel degradation during the 8-day study. At predetermined
time-points, solution (100 ml) was removed with replacement, to minimize hydrogel disruption. The activity of the
collected sample was measured in a scintillation counter,
with the hydrogel also measured at the final time point. The
percentage of DNA released was calculated by dividing the
amount released at a given time-point by the initial amount
immobilized.
Cell Culture and Transfection
All transfection studies were performed using an NIP ratio
of 5 with complexes formed in either 150 mm NaCl or water.
NIHl3T3 cells, a fibroblast cell line, were used to simulate
in vivo delivery to fibroblasts (Bonadio J, Smiley E, Patil P,
Goldstein S., Nat Med 1999;5 (7):753-9). Cells were plated
(10,000 cellslwell) on the modified hydrogel substrates and
cultured for 2 days at 37' C. and 5% CO, in DMEM
(Invitrogen, Gaithersburg, Md.) supplemented with 10%
heat-inactivated FBS and 1% penicillidstreptomycin. The
ability of complexes released from the hydrogel to promote
gene transfer was examined by placing the hydrogels in
culture above NIHl3T3 cells (15,000 cellslwell) in 48-well
plates. The DNA-modified hydrogels were not in direct
contact with the adhered cells. Additionally, cellular interactions with the immobilized DNA complex was investigated through incorporation of an RGD peptide into the
complex, which increase cellular interactions with the comthrough integrin receptor binding to RGD
K,
Merdan T, Hegener 0 , Haberlein H, Kissel T., J Gene Med
2003;5(7):588-99). Complexes were formed with a constant
amount of PEIBiotin (25%) and varying amounts of RGDpEI (10-75%). The extent of transgene
exllression elicited
u
by the DNA-modified surfaces was examined using the
reporter genes luciferase. For measurements of luciferase
activity, the cells were lysed and assayed for luciferase
enzymatic activity (Promega, Madison, Wis.). The luminometer was set for a 3-s delay and an integration of the
signal for 10 s. Transgene expression of luciferase is
reported as RLU per number of cells seeded. The number
and distribution of transfected cells was determined with
green fluorescent protein (GFP) expression and fluorescence
microscopy. Complexes with 25% biotinylated PEI were
immobilized onto the hydrogel surface. NIHl3T3 cells (7000
cellslwell) were plated on topographically patterned-DNA
modified hydrogels and cultured for 48 h. The cytoskeleton
and nucleus of cells were stained with rhodamine phalloidin
(1 Ul200 ml) and Hoechst (1 mglml) stains, respectively
(Molecular Probes, Eugene, Oreg.). Five pictures per triplicate were taken with a fluorescence microscope and analyzed. The percentage of transfected cells was calculated as
the ratio of GFP-positive cells to total number of nuclei
(Hoechst).
Results
DNMPEI Complex Characterization
The dependence of the z-average diameter (dz) for the
DNA complexes was determined at two salt concentrations
(150 mm NaCl, pure water) and varying NIP ratio. dz for
PEIlDNAcomplexes was an order of magnitude larger in the
presence of salt (FIG. 25A). At an NIP ratio of 5, dz was
equal to 139.4+1-1.3 nm in water, and 1221.7+1-152.3 nm
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in 150 mm NaCl. Additionally, complex diameter decreased
with increasing NIP ratio in both 150 mm NaCl and water
(FIG. 25A). For 150 mm NaCl, dz ranged from 848.9+163.6 ~1 (NIP 20) to 1778+1-227.7 ~1 (NIP 2.5). In water,
dz ranged from 125.6+1-2.3 nm
20) 173.9+1-2.2 nm
(NIP 2.5). The zeta potential of complexes in 150 mm NaCl
also increased with increasing NIP ratio with values ranging
from -11.0+1-2.3 mV to 24.4+1-0.6 mV for complexes
formed with 2.5 and 20 NIP ratios, respectively (FIG. 25B).
Complexes formed in the absence of salt aggregated upon
addition of salt, ~h~ dz was monitored before and after salt
addition for a total tirne of76 min (FIG, 26). ~h~ complexes
increased in size upon salt addition, with dz increasing from
139,7+/-1,3 nm to 342,7+1-12,8 nm immediately after salt

48.7+1-5.4% of adhered cells, whereas large diameter complexes resulted in a transfection percentage of 22.3+1-5.8%
(FIG. 30B).

addition for an NIP ratio of 5, PEI/DNA complex dz
increased further with increased incubation time, reaching
758.7+1-53.8 nm after 76 min of incubation. This trend of
increasing complex diameter with salt and time was
observed for all NIP ratios (FIG. 26).
Surface Immobilization
DNA immobilization to the hydrogel was independent of
salt content during complex formation and the extent of
biotinylation, Quantities immobilized to the hydrogels
ranged from 0,411+1-0,042 to 0,484+1-0,014 mg DNA,
with no significant difference between conditions (p>0.05;
FIG, 27A). Immobilization preserved the complex size that
was observed in solution, Complexes formed in salt and
deposited on the surface were visualized as discrete particles
on the surface (FIG, 2 7 ~ )conversely,
.
complexes formed in
water resulted in more diffuse fluorescence without large
aggregates, consistent with small particle deposition (FIG,
27C).
Cellular Transfection
Complexes with plasmid encoding for GFP were immobilized to the topographically patterned hydrogel substrates
in order to visualize the distribution of transfected cells,
NIH/3T3 cells plated and cultured on HA-collagen hydrogels oriented consistently with the pattern on the hydrogel
surface. Visualization of the cytoskeleton (phalloidin) by
fluorescence microscopy demonstrated that the cells were
aligned with the pattern. Additionally, NIH/3T3 cells culbred on the DNA-modified hydrogel substrates were found
to express the transgene in this oriented conformation (FIG.
28).
The role of complex size, which was regulated by salt
content during complex formation, in gene transfer for
substrate-mediated delivery was examined by measuring the
extent of transgene expression and percentage of transfected
cells. Complex size significantly affected transgene expression, with large diameter complexes (formed in NaCl)
resulting in increased luciferase expression relative to small
diameter complexes (formed in water, FIG. 29). Maximal
transgene expr5ssion levels were 1.62+1-0.67x105 and
4.28+1-0.62~10 (RLUl10,OOO cells) for the large and smalldiameter complexes, respectively (FIG. 29). Furthermore,
complexes formed with biotinylated PEI resulted in statistically higher luciferase expression than non-biotinylated
complexes (pe0.05; FIG. 29). No difference in expression
was observed for complexes formed with different extents of
biotinylation (p>0.05). The percentage of transfected cells
by the different complexes was subsequently examined to
determine if increased luciferase production correlated with
a higher percentage of transfected cells (FIG. 30A). However, small diameter complexes resulted in transfection of
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Mechanism of DNA Internalization
The mechanism of DNAinternalization from the substrate
was examined by examining release from the substrate, the
ability of released complexes to transfect cells, and the role
of speci.c cellular interactions with the complexes. Incubation of hydrogels with immobilized DNA complexes in PBS
(FIG. 31A), conditioned media (FIG. 31B), and hyaluronidase (FIG. 31C) indicated that complexes were released
from the substrate, with conditioned media producing the
maximal release. After 24-h incubation, conditioned media
induced release for approximately 50% of the immobilized
DNA, which is substantially greater than release in either
PBS or hyaluronidase. Release of biotinylated or nonbiotinylated complexes was significantly different (pe0.05)
primarily at the
time point, with the greatest difference
observed for release in conditioned media.
After 8-day incubation in PBS, conditioned media, and
hyaluronidase, the percentage of non-biotinylated complexes released was 51.6+1-1.5, 58.7+1-6.4, and 78.6+18.8%, respectively. For biotinylated complexes, the percentwas 43.4+1-5.3, 83.3+1-3.1, and
age
94.7+1-0.5% for substrates incubated in PBS, conditioned
media, and hyaluronidase,
Incubation of DNA-immobi1ized hydrogels with NIH1
3T3
On tissue
polystyrene was perfo'med to assess the role of cellular adhesion to the substrate
1" gene transfer. Complexes released from the hydrogel did
not efficiently transfect cells that were not cultured on the
substrate
32). Luciferase
was 01 RLU=lO;
000 cells by incubation of hydrogels with cells cultured on
polystyrene, which is significantly less than expression
levels observed when cells were cultured on the hydrogel
(>105RLU=10; OoO
Inc0qoration RGD peptides
the DNA
which was hypothesized to increase cellular interactions
RGD binding integrin recepwith the
tors, resulted in lower transgene expression than unmodified
complexes (FIG. 33). For all the conditions tested, the
presence
RGD in the
decreased transgene
expression relative to the absence of RGD ~ e ~ t i d e1n
s . the
was .24+1absence RGD peptides, transgene
0.08x105 RLU1lO,OOO
The Presence RGD at levels
of 10% and 25% resulted in mean expression levels of
approximately 7 x 1 0 ~RLUl10,OOO cells. Further increases in
PEI-RGD content to 50% and 75% reduced mean transgene
expression to less than 2x104 RLUl10,OOO cells.
Summary of Example 6
Complexes formed in the presence of salt had a z-average
diameter equal to 1221.7+1-152.3 nm, while formation in
water produced complexes with z-average diameter of
139.4+1-1.3 nm. Complexes immobilized to the hydrogel
had sizes consistent with their size in solution, and did not
aggregate. The quantity of complexes immobilized was
independent of the complex size and the extent of biotinylation. DNA release from the hydrogel substrate was
enhanced by incubation with conditioned media, with
release at 48 h equal to 49.7+1-8.1% and 49.2+1-2.9% for
non-biotinylated and biotinylated complexes, respectively.
Transfection studies showed that transgene expressionmediated by large complexes was 3- to 7-fold greater than with
small complexes. However, the number of cells expressing
the transgene was increased with small complexes (48.7%),
relative to large complexes (22.3%). Finally, the hydrogel
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was patterned topographically, which guided and oriented
cell attachment to the substrate and resulted in spatial
patterns of transfected cells on the hydrogel.
In summary, efficient and controlled DNA delivery from
biomaterial substrates has the potential to enhance the
applicability of gene delivery to tissue engineering. We have
fabricated hydrogels with the ability to transfect adherent
cells using immobilized DNA complexes, which can be
manipulated to alter the number of transfected cells and the
extent of transgene expression. Additionally, these hydrogels can be patterned to regulate cell attachment and orient
cell growth, which results in spatial patterns of transfected
cells.
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TABLE I
Contact Angle Measurements for Substrates (water)
Sufiace
Tissue Culture Polystyrene (PS)
FBS Modified Tissue Culture polystyrene (FBS-PS)

47.75 +/- 6.64
12.67 +I- 3.13

lo

15

Example 7
Patterned Transfection on Gold Substrates
20

Self-assembled monolayers (SAMs) of alkanethiols on
gold were used to spatially pattern surfaces with chemically
active groups to regulate the location of DNA delivery from
the surface (FIGS. 34 and 35). A self-assembled monolayer
is a single layer of molecules on a substrate in which the
molecules exhibit a high degree of orientation, molecular
and packing. The monolayer
forms
upon exposure of the substrate to an ethanol solution containing the molecules. Alkanethiols form well-packed and
stable monolayers on gold through a thiolate linkage. A
poly(dimethylsiloxane) (PDMS) stamp was used to imprint
gold surfaces with specific patterns of SAM^ of mercapto1-undecanol (MUOH) or 11-mercaptoundecanoic acid
(WA) according to the method of ulman, A, (1996).
Formation and Structure of Self-Assembled Monolayers,
Chem Rev 96, 1533-1554. The stamped surface was then
immersed into a solution of 2 mM 1-decanethiol (DTlO),
creating regions with different properties allowing for physically distinct regions of complexes. Complexes were formed
with a plasmid encoding for eGFPILuciferase, complexed
with Lipofectamine at a 1:2.5 DNA: Lipofectamine ratio.
The complexes were then deposited on the surface for 2
hours. The surfaces were then washed and NIHl3T3 fibroblasts were seeded. Luciferase expression was assayed 24
hours later. Alternatively, cells were seeded onto the
alkanethiol modified gold surface and DNA complexes were
then added as a bolus.
As shown in FIG. 35, complexes adsorbed on the hydrophilic, charged MUA transfected with greater efficiency than
On MUOH, DT1O,Or
the umnOdified
gold surface. Very little
was transfected when DNA
was delivered as a bolus.
The present invention is not to be limited in terms of the
particular embodiments described in this application, which
are intended as single illustrations of individual aspects of
the invention. Functionally equivalent methods and apparatus within the scope of the invention, in addition to those
enumerated herein, will be apparent to those skilled in the art
from the foregoing description and accompanying drawings.
Such modifications and variations are intended to fall within
the scope of the appended claims. The contents of each
reference, patent and patent application cited in this application is hereby incorporated by reference in its entirety.
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What is
is:
1. A method for increasing transgene expression, cornprising making a
nucleic acid
system,
said system comprising forming nucleic acid polylinker
complexes capable of being delivered to cells cultured on a
support substrate, wherein said complexes are formed prior
to being covalently or non-covalently immobilized to the
surface of a support substrate, and wherein said method
comprises:
a) contacting a nucleic acid with a polylinker to form a
nucleic acid-polylinker complex, said complex being
formed prior to attachment to a support substrate; and
b,
the
acid-~ol~linker
to a
support substrate; and
wherein said cells are added to the support substrate after
immobilization of the nucleic acid-polylinker complex to the
support substrate,
2. The method of claim 1, further comprising modification
of the
substrate with serum prior to addition of the
nucleic acid-polylinker complex, and wherein said modification allows for an increase in transgene expression.
3. The method of claim 1,wherein the extent of transgene
expression is dependent upon substrate modification and
4. The method of claim 1, wherein said nucleic acid
~
~ are PY ~ ~~ Or Ylip0plexes.
~P ~ ~~ ~
5' The method of
wherein said
substrate
is polystyrene, gold, hyaluronic acid collagen hydrogels or
polylactide-co-glycolide (PLG),
6, The method of claim 2, wherein said substrate modification is made by treatment with serum,
7, l-he method ofclaim 1, wherein delivery of the nucleic
acid-polylinker complexes to cells occurs from a polystyrene surface treated with serum, and wherein said delivery
results in similar or greater percentage of transfected cells
relative to bolus delivery.
8. The method of claim 1, said method further comprising
release of the nucleic acid from the nucleic acid-polylinker
complexes, wherein said release is maximized when the
support substrate is treated with serum.
9. A method for increasing transgene expression, comprising making a controlled nucleic acid delivery system,
said system comprising forming nucleic acid polyli&er
complexes capable of being delivered to cells cultured on a
support substrate, wherein said complexes are covalently or
non-covalently immobilized to the surface of a support
substrate, and wherein said method comprises:
a) contacting a nucleic acid with a polylinker to form a
nucleic acid-polylinker complex;
b) immobilizing the nucleic acid-polylinker complex to a
support substrate; and
c) adding cells to the support substrate after immobilization of the nucleic acid-polylinker complex to the
support substrate,
wherein the release of nucleic acid from the nucleic
acid-polylinker complexes is further enhanced when

P

~~

~ ~

the support substrate containing the complexes is
17. The method of either one of claim 1 or 11, wherein
treated with serum or is incubated in conditioned
said nucleic acid polylinker complexes are immobilized to
medium.
the support substrate using biotin and avidin, or an avidin
10. The method of claim 2, wherein the delivery of the
derivative, or by non-specific adsorption.
18. The method of claim 17, wherein said avidin derivanucleic acid-polylinker complexes to cells from a serum- 5
modified support substrate results in higher cellular assotive is streptavidin or neutravidin.
ciation of the nucleic acid-polylinker complexes with the
19. The method of any one of claim 11-15, wherein the
support substrate.
method further comprises controlling the size of the nucleic
11. A method for increasing transgene expression, comacid polylinker complex by regulating the salt content
l o during complex formation.
prising the steps of
a) making a controlled nucleic acid delivery system by
20. The method of claim 19, wherein controlling the size
contacting a nucleic acid with a polylinker to form a
of said complex formation is accomplished by the presence
nucleic acid-polylinker complex, wherein said complex
or absence of salt during the formation of the complexes,
is formed prior to addition to a support substrate;
wherein the forming of large diameter complexes in the
b) immobilizing the nucleic acid-polylinker complex to a 1s presence of salt results in increased transgene expression,
support substrate; wherein said immobilizing is accomand wherein the forming of small diameter complexes in the
plished by covalent or non-covalent means, and
absence of salt results in a greater percentage of cells being
c) adding the cells into which transgene expression is
transfected.
21. The method of claim 19, wherein the salt is sodium
desired to the support substrate after immobilization of
the nucleic acid-polylinker complex to the support 20 chloride.
22. A method for increasing transgene expression, comsubstrate.
12. The method of claim 11, wherein said support subprising the steps of
strate comprises a biodegradable or non-biodegradable
a) making a controlled nucleic acid delivery system by
material.
contacting a nucleic acid with a polylinker to form a
13. The method of either one of claim 1 or 11, wherein 25
nucleic acid-polylinker complex;
said complexes are formed prior to attachment to the solid
b) immobilizing the nucleic acid-polylinker complex to a
support substrate.
support substrate; wherein said immobilizing is accom14. The method of claim 12, wherein said biodegradable
plished by covalent or non-covalent means, and
material is a hydrogel and said non-biodegradable material
c) adding the cells into which transgene expression is
30
desired to the support substrate after immobilization of
is polystyrene or gold.
15. The method of claim 12, wherein said hydrogel
the nucleic acid-polylinker complex to the support
comprises a mixture of hyaluronic acid and collagen.
substrate,
16. A method for increasing transgene expression,
wherein said method further comprises release of the nucleic
wherein said method promotes transfection of primary cells,
acid from the substrate, wherein the release is optimized by
35 using conditioned medium.
comprising the steps o f
23. The method of claim 11, wherein said method further
a) making a controlled nucleic acid delivery system by
contacting a nucleic acid with a polylinker to form a
comprises biotinylation of said complex to enhance release
nucleic acid-polylinker complex;
of said complex from said substrate.
24. The method of either of claim 1 or 11, wherein the
b) immobilizing the nucleic acid-polylinker complex to a
support substrate; wherein said immobilizing is accom- 40 nucleic acid is DNA, RNA or an oligonucleotide.
25. The method of claim 24, wherein said oligonucleotide
plished by covalent or non-covalent means, and
c) adding the cells into which transgene expression is
is an antisense oligonucleotide or a catalytic RNAcapable of
desired to the support substrate after immobilization of
interfering with the expression of a gene.
26. The controlled nucleic acid delivery system of either
the nucleic acid-polylinker complex to the support
substrate, wherein the biodegradable material is a 45 of claim 1 or 11, wherein the polylinker is a cationic
hydrogel and the non-biodegradable material is polypolymer, cationic lipid, cationic protein, or cationic peptide.
styrene or gold, and wherein the hvdrogel comprises a
* * * * *
mixture of hyaluronic acid and collagen.

